Rank;Sourceid;Title;Type;Issn;SJR;SJR Best Quartile;H index;Total Docs. (2018);Total Docs. (3years);Total Refs.;Total Cites (3years);Citable Docs. (3years);Cites / Doc. (2years);Ref. / Doc.;Country;Publisher;Coverage;Categories
1;20425;Nature Reviews Drug Discovery;journal;14741776;9.483;Q1;289;206;678;9103;6648;321;18.76;44.19;United Kingdom;Nature Publishing Group;2002-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
2;21191;Pharmacological Reviews;journal;15210081, 00316997;7.422;Q1;210;26;78;8975;1458;75;19.51;345.19;United States;American Society for Pharmacology and Experimental Therapeutics;1949-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
3;19479;Annual Review of Pharmacology and Toxicology;journal;15454304, 03621642;6.609;Q1;193;33;92;148;1133;91;11.58;4.48;United States;Annual Reviews Inc.;1965-1973, 1975-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
4;4700152457;Nano Today;journal;17480132;6.236;Q1;119;52;164;8226;2421;137;16.19;158.19;Netherlands;Elsevier BV;2006-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
5;22321;Trends in Pharmacological Sciences;journal;01656147;4.586;Q1;201;93;290;7123;2878;252;9.93;76.59;Netherlands;Elsevier BV;1979-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
6;12611;Drug Resistance Updates;journal;13687646, 15322084;4.319;Q1;100;18;71;3179;934;70;11.65;176.61;United States;Churchill Livingstone;1998-ongoing;"Cancer Research (Q1); Infectious Diseases (Q1); Oncology (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
7;19409;Advanced Drug Delivery Reviews;journal;0169409X;4.163;Q1;278;213;517;33956;7153;472;16.04;159.42;Netherlands;Elsevier BV;1987-ongoing;Pharmaceutical Science (Q1)
8;21195;Pharmacology and Therapeutics;journal;01637258;3.586;Q1;180;161;392;29950;3959;392;9.09;186.02;United Kingdom;Elsevier Ltd.;1975-1977, 1979-1985, 1987-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
9;26371;Natural Product Reports;journal;02650568, 14604752;3.552;Q1;157;76;221;9913;2250;209;10.7;130.43;United Kingdom;Royal Society of Chemistry;1984-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Organic Chemistry (Q1)"
10;21100466864;Journal for ImmunoTherapy of Cancer;journal;20511426;3.337;Q1;36;153;276;6314;1867;241;8.66;41.27;United Kingdom;BioMed Central;2014-ongoing;"Cancer Research (Q1); Immunology (Q1); Immunology and Allergy (Q1); Molecular Medicine (Q1); Oncology (Q1); Pharmacology (Q1)"
11;12455;Molecular Therapy;journal;15250024, 15250016;3.288;Q1;158;268;736;13149;4438;606;7.47;49.06;United States;Cell Press;2000-ongoing;"Drug Discovery (Q1); Genetics (Q1); Medicine (miscellaneous) (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
12;18017;Neuropsychopharmacology;journal;0893133X;3.205;Q1;204;353;945;18375;5825;839;7.06;52.05;United Kingdom;Nature Publishing Group;1987-ongoing;"Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
13;21100854844;International Journal of Pharmaceutical Investigation;journal;22309713, 2230973X;3.169;Q1;2;0;2;0;21;1;0;0.00;India;Wolters Kluwer Medknow Publications;2015;Pharmaceutical Science (Q1)
14;13903;Cellular and Molecular Life Sciences;journal;1420682X, 14209071;3.006;Q1;194;297;907;32157;5876;884;7.03;108.27;Switzerland;Birkhauser Verlag;1997-ongoing;"Cell Biology (Q1); Cellular and Molecular Neuroscience (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
15;21100456838;Cell Chemical Biology;journal;24519448, 24519456;2.945;Q1;166;168;552;8131;2723;517;5.15;48.40;United States;Elsevier Inc.;2016-ongoing;"Biochemistry (Q1); Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Biology (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
16;18148;Pain;journal;03043959;2.766;Q1;238;265;1054;6284;5108;822;5.76;23.71;United States;Lippincott Williams & Wilkins Ltd.;1975-ongoing;"Anesthesiology and Pain Medicine (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
17;11900154404;PLoS Neglected Tropical Diseases;journal;19352727, 19352735;2.669;Q1;110;811;2674;35548;11522;2541;4.4;43.83;United States;Public Library of Science;2007-ongoing;"Infectious Diseases (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Public Health, Environmental and Occupational Health (Q1)"
18;20084;British Journal of Pharmacology;journal;00071188;2.665;Q1;190;383;1067;25484;6503;1013;6.48;66.54;United States;Wiley-Blackwell;1958, 1965-ongoing;Pharmacology (Q1)
19;5100155080;Neurotherapeutics;journal;19337213;2.565;Q1;100;100;268;8466;1452;238;5.5;84.66;United States;Springer New York LLC;2007-ongoing;"Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
20;19907;Medicinal Research Reviews;journal;01986325, 10981128;2.528;Q1;119;71;108;14939;946;104;9.75;210.41;United States;John Wiley & Sons Inc.;1981-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
21;21100850730;npj Vaccines;journal;20590105;2.527;Q1;8;55;52;2792;239;48;4.98;50.76;United Kingdom;Nature Publishing Group;2016-ongoing;"Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
22;23010;Journal of Controlled Release;journal;01683659;2.411;Q1;237;497;1601;36474;12469;1514;7.94;73.39;Netherlands;Elsevier BV;1984-ongoing;Pharmaceutical Science (Q1)
23;20681;Current Opinion in Pharmacology;journal;14714892;2.296;Q1;120;117;331;6542;1697;300;5.24;55.91;Netherlands;Elsevier BV;2001-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
24;23041;Journal of Medicinal Chemistry;journal;00222623, 15204804;2.287;Q1;240;761;2207;44536;13756;2133;6.26;58.52;United States;American Chemical Society;1963-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
25;19600166320;Protein & Cell;journal;16748018, 1674800X;2.28;Q1;48;138;307;6747;1208;220;5.52;48.89;Germany;Springer Verlag;2010-ongoing;"Biochemistry (Q1); Biotechnology (Q1); Cell Biology (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1)"
26;21196;Drug Discovery Today;journal;13596446;2.248;Q1;157;223;586;16093;4122;560;6.86;72.17;Netherlands;Elsevier BV;1996-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
27;21100207003;Theranostics;journal;18387640;2.176;Q1;69;452;668;25482;5405;649;8.02;56.38;Canada;Ivyspring International Publisher;2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
28;22418;Journal of Antimicrobial Chemotherapy;journal;03057453, 14602091;2.139;Q1;172;559;1533;17555;6482;1297;4.94;31.40;United Kingdom;Oxford University Press;1975-ongoing;"Infectious Diseases (Q1); Microbiology (medical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
29;21100335701;Vaccines;journal;2076393X;2.136;Q1;24;83;150;6256;815;145;4.93;75.37;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Drug Discovery (Q1); Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
30;21100232818;Emerging Microbes and Infections;journal;22221751;2.117;Q1;31;214;251;8922;1095;191;5.84;41.69;United Kingdom;Nature Publishing Group;2012-ongoing;"Drug Discovery (Q1); Epidemiology (Q1); Immunology (Q1); Infectious Diseases (Q1); Medicine (miscellaneous) (Q1); Microbiology (Q1); Parasitology (Q1); Virology (Q1)"
31;19615;Antimicrobial Agents and Chemotherapy;journal;10986596, 00664804;2.096;Q1;232;946;3152;32792;13633;2928;4.68;34.66;United States;American Society for Microbiology;1963-1970, 1972-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
32;15984;Journal of Molecular Medicine;journal;09462716, 14321440;2.015;Q1;127;111;383;6405;1575;336;4.75;57.70;Germany;Springer Verlag;1976-1978, 1980-1981, 1995-ongoing;"Drug Discovery (Q1); Genetics (clinical) (Q1); Molecular Medicine (Q1)"
33;21100218543;Molecular Therapy - Nucleic Acids;journal;21622531;2.011;Q1;43;220;338;11814;1939;324;5.67;53.70;United States;Cell Press;2012-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1)"
34;21100225611;Advanced healthcare materials;journal;21922640, 21922659;1.965;Q1;63;363;910;35461;5436;871;5.95;97.69;United Kingdom;John Wiley and Sons Ltd;2012-ongoing;"Biomaterials (Q1); Biomedical Engineering (Q1); Pharmaceutical Science (Q1)"
35;21165;PharmacoEconomics;journal;11707690;1.942;Q1;91;154;322;5942;1180;277;3.63;38.58;United Kingdom;Adis International Ltd.;1992-ongoing;"Health Policy (Q1); Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1)"
36;15576;European Neuropsychopharmacology;journal;0924977X;1.911;Q1;100;127;561;7679;2456;528;4.55;60.46;Netherlands;Elsevier BV;1990-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Biological Psychiatry (Q2)"
37;20700195026;Acta Pharmaceutica Sinica B;journal;22113843, 22113835;1.893;Q1;28;99;233;5718;1593;217;6.15;57.76;Netherlands;Elsevier BV;2014-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
38;19963;Molecular Pharmacology;journal;15210111, 0026895X;1.858;Q1;186;138;498;6537;1761;466;3.61;47.37;United States;American Society for Pharmacology and Experimental Therapeutics;1965-ongoing;"Molecular Medicine (Q1); Pharmacology (Q1)"
39;22452;International Journal of Neuropsychopharmacology;journal;14611457, 14695111;1.846;Q1;93;139;427;7871;1874;401;4.37;56.63;United Kingdom;Oxford University Press;1998-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
40;20626;Clinical Pharmacology and Therapeutics;journal;00099236;1.842;Q1;173;322;586;10578;2599;503;5.26;32.85;United States;Wiley-Blackwell;1960-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
41;26380;Drug and Alcohol Dependence;journal;03768716;1.821;Q1;151;464;1349;21412;5163;1306;3.59;46.15;Netherlands;Elsevier BV;1975-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
42;21169;Pharmacological Research;journal;10436618, 10961186;1.781;Q1;118;354;922;32228;4847;846;5.78;91.04;United States;Elsevier Inc.;1989-ongoing;Pharmacology (Q1)
43;20435;Neuropharmacology;journal;00283908;1.78;Q1;150;511;1260;38388;5507;1234;4.43;75.12;United Kingdom;Elsevier Ltd.;1962-ongoing;"Pharmacology (Q1); Cellular and Molecular Neuroscience (Q2)"
44;24749;Addiction Biology;journal;13556215, 13691600;1.755;Q1;70;192;351;7662;1448;344;4.22;39.91;United States;Wiley-Blackwell;1996-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Psychiatry and Mental Health (Q1)"
45;19700178100;Nanotechnology, Science and Applications;journal;11778903;1.755;Q1;23;2;26;178;254;25;7.42;89.00;New Zealand;Dove Medical Press Ltd.;2010-2012, 2014-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
46;21100819608;Emerging Contaminants;journal;24056650, 24056642;1.701;Q1;9;5;52;267;265;50;4.84;53.40;China;KeAi Communications Co;2015-ongoing;"Health, Toxicology and Mutagenesis (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1)"
47;23916;Environmental Pollution;journal;02697491, 18736424;1.673;Q1;194;1493;2547;86792;15198;2505;5.95;58.13;United Kingdom;Elsevier Ltd.;1970-1980, 1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Pollution (Q1); Toxicology (Q1)"
48;23109;Journal of Psychopharmacology;journal;02698811;1.672;Q1;106;143;435;7768;1953;401;4.28;54.32;United States;SAGE Publications;1987-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
49;4400151524;Particle and Fibre Toxicology;journal;17438977;1.661;Q1;83;47;159;2843;1033;149;6.92;60.49;United Kingdom;BioMed Central;2004-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
50;19617;Antiviral Research;journal;01663542;1.656;Q1;108;228;642;11695;2687;635;4.12;51.29;Netherlands;Elsevier BV;1959, 1981-ongoing;"Pharmacology (Q1); Virology (Q1)"
51;145164;Human Genomics;journal;14739542, 14797364;1.632;Q1;49;51;104;2573;342;97;2.55;50.45;United Kingdom;BioMed Central;2003-2006, 2008-ongoing;"Drug Discovery (Q1); Genetics (Q1); Molecular Medicine (Q1); Molecular Biology (Q2)"
52;5400152706;Nanotoxicology;journal;17435390, 17435404;1.617;Q1;72;90;371;5111;2224;357;6.31;56.79;United Kingdom;Informa Healthcare;2007-ongoing;"Biomedical Engineering (Q1); Nanoscience and Nanotechnology (Q1); Toxicology (Q1)"
53;24604;Archives of Toxicology;journal;14320738, 03405761;1.609;Q1;96;291;742;15857;3798;637;5.66;54.49;Germany;Springer Verlag;1972-ongoing;"Health, Toxicology and Mutagenesis (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q1)"
54;25152;Journal of Toxicology and Environmental Health - Part B: Critical Reviews;journal;10937404, 15216950;1.606;Q1;70;17;54;2057;335;51;6.64;121.00;United Kingdom;Taylor & Francis;1998-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
55;4700152848;PPAR Research;journal;16874757, 16874765;1.605;Q1;40;18;85;960;365;82;4.14;53.33;Egypt;Hindawi Publishing Corporation;2006-ongoing;"Drug Discovery (Q1); Pharmacology (medical) (Q1)"
56;20783;Expert Review of Vaccines;journal;14760584;1.603;Q1;75;103;363;8333;1324;327;4.37;80.90;United Kingdom;Taylor & Francis;2002-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1); Immunology (Q2)"
57;20051;BioDrugs;journal;11738804;1.601;Q1;60;62;133;3675;627;124;4.87;59.27;United Kingdom;Adis International Ltd.;1997-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
58;110112;Journal of immunotherapy (Hagerstown, Md. : 1997);journal;15249557;1.568;Q1;89;56;131;1962;513;130;3.26;35.04;United States;Lippincott Williams & Wilkins Ltd.;1994-ongoing;"Immunology and Allergy (Q1); Pharmacology (Q1); Cancer Research (Q2); Immunology (Q2)"
59;16876;Bioconjugate Chemistry;journal;15204812, 10431802;1.551;Q1;161;443;950;22767;4281;919;4.38;51.39;United States;American Chemical Society;1990-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1)"
60;20082;British Journal of Clinical Pharmacology;journal;13652125, 03065251;1.53;Q1;131;329;877;12345;3110;746;3.98;37.52;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
61;20624;Clinical Pharmacokinetics;journal;03125963;1.529;Q1;150;141;347;8067;1482;310;4.57;57.21;United Kingdom;Adis International Ltd.;1976-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
62;19700174913;Therapeutic Advances in Neurological Disorders;journal;17562864, 17562856;1.521;Q1;40;80;112;4715;453;101;4.22;58.94;United Kingdom;SAGE Publications;2008-ongoing;"Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1)"
63;4000149101;Nanomedicine: Nanotechnology, Biology, and Medicine;journal;15499634, 15499642;1.508;Q1;106;238;664;11758;3923;645;5.62;49.40;Netherlands;Elsevier BV;2005-ongoing;"Bioengineering (Q1); Biomedical Engineering (Q1); Materials Science (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Molecular Medicine (Q1); Nanoscience and Nanotechnology (Q1); Pharmaceutical Science (Q1)"
64;14990;Current Neuropharmacology;journal;1570159X;1.49;Q1;58;115;286;14411;1219;250;4.16;125.31;United Arab Emirates;Bentham Science Publishers;2004-ongoing;"Medicine (miscellaneous) (Q1); Neurology (Q1); Neurology (clinical) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
65;4000148203;Handbook of Experimental Pharmacology;book series;01712004;1.489;Q1;81;91;362;9853;1118;161;15.55;108.27;Germany;Springer Verlag;2005-ongoing;"Biochemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
66;19900193739;Nucleic Acid Therapeutics;journal;21593345, 21593337;1.488;Q1;61;38;118;2082;384;116;3.8;54.79;United States;Mary Ann Liebert Inc.;2011-ongoing;"Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Genetics (Q2); Molecular Biology (Q2)"
67;21767;Progress in Neuro-Psychopharmacology and Biological Psychiatry;journal;02785846;1.484;Q1;114;283;501;26793;2099;488;4.44;94.67;Netherlands;Elsevier BV;1982-ongoing;"Pharmacology (Q1); Biological Psychiatry (Q2)"
68;20063;Biochemical Pharmacology;journal;00062952;1.483;Q1;181;403;804;28636;3536;746;4.98;71.06;Netherlands;Elsevier BV;1958-ongoing;"Biochemistry (Q1); Pharmacology (Q1)"
69;21354;Expert Opinion on Therapeutic Targets;journal;14728222;1.47;Q1;78;91;363;9256;1493;334;4.64;101.71;United Kingdom;Taylor & Francis;1997-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Molecular Medicine (Q1); Pharmacology (Q1)"
70;24791;Alcoholism: Clinical and Experimental Research;journal;01456008, 15300277;1.463;Q1;143;243;821;13474;2520;757;3.26;55.45;United States;Wiley-Blackwell;1977-ongoing;"Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
71;6800153101;Expert Opinion on Drug Discovery;journal;1746045X, 17460441;1.45;Q1;50;107;310;9367;1406;284;4.34;87.54;United Kingdom;Informa Healthcare;2006-ongoing;Drug Discovery (Q1)
72;24661;Critical Reviews in Toxicology;journal;15476898, 10408444;1.442;Q1;98;45;111;5406;584;106;4.71;120.13;United Kingdom;Taylor & Francis;1971-ongoing;Toxicology (Q1)
73;21237;Drug Safety;journal;01145916;1.438;Q1;115;149;334;5425;1154;277;3.64;36.41;United Kingdom;Adis International Ltd.;1990-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1)"
74;24763;Addictive Behaviors;journal;03064603;1.418;Q1;114;433;905;18870;3011;893;3.2;43.58;United Kingdom;Elsevier Ltd.;1975-ongoing;"Clinical Psychology (Q1); Medicine (miscellaneous) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
75;144771;Clinical Trials;journal;17407753, 17407745;1.417;Q1;55;79;277;2302;500;218;2.22;29.14;United States;SAGE Publications;2004-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
76;21100857212;Current Opinion in Systems Biology;journal;24523100;1.417;Q1;6;74;119;4679;222;106;2.09;63.23;United Kingdom;Elsevier Ltd;2017-ongoing;"Applied Mathematics (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Computer Science Applications (Q1); Drug Discovery (Q1); Modeling and Simulation (Q1)"
77;130126;Molecular Pharmaceutics;journal;15438384, 15438392;1.402;Q1;110;550;1288;26152;6040;1268;4.57;47.55;United States;American Chemical Society;2004-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
78;21782;Psychopharmacology;journal;00333158;1.395;Q1;181;339;1064;21486;3703;1015;3.68;63.38;Germany;Springer Verlag;1959-ongoing;Pharmacology (Q1)
79;23086;Journal of Pharmacology and Experimental Therapeutics;journal;15210103, 00223565;1.383;Q1;209;229;677;12170;2464;644;3.65;53.14;United States;American Society for Pharmacology and Experimental Therapeutics;1945-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
80;19700175015;Infection and Drug Resistance;journal;11786973;1.354;Q1;27;263;134;10708;498;128;3.06;40.71;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
81;22552;Cardiovascular Drugs and Therapy;journal;15737241, 09203206;1.338;Q1;63;74;200;2705;638;175;4;36.55;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Cardiology and Cardiovascular Medicine (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
82;84948;Expert Opinion on Drug Delivery;journal;17425247;1.337;Q1;88;96;406;9346;2067;376;5.27;97.35;United Kingdom;Taylor & Francis;2004-ongoing;Pharmaceutical Science (Q1)
83;4700152872;Journal of NeuroImmune Pharmacology;journal;15571890, 15571904;1.333;Q1;64;58;190;3810;687;183;3.76;65.69;Germany;Springer Verlag;2006-ongoing;"Pharmacology (Q1); Immunology (Q2); Immunology and Allergy (Q2); Neuroscience (miscellaneous) (Q2)"
84;21332;European Journal of Pharmaceutics and Biopharmaceutics;journal;09396411;1.326;Q1;138;336;846;16045;4424;831;4.85;47.75;Netherlands;Elsevier BV;1991-ongoing;"Biotechnology (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
85;21000196010;Topics in antiviral medicine;journal;21615853;1.323;Q1;37;16;58;280;151;58;3.58;17.50;United States;International Antiviral Society;2011-ongoing;"Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Virology (Q2)"
86;18403;Apoptosis : an international journal on programmed cell death;journal;13608185, 1573675X;1.313;Q1;102;58;376;3058;1531;363;4.1;52.72;Netherlands;Kluwer Academic Publishers;1996-ongoing;"Biochemistry (medical) (Q1); Clinical Biochemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Cancer Research (Q2); Cell Biology (Q2)"
87;4000148406;Clinical Toxicology;journal;15563650;1.298;Q1;85;215;452;4413;1260;289;4.36;20.53;United Kingdom;Taylor & Francis;1968-1998, 2005-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
88;25218;Toxicological Sciences;journal;10960929, 10966080;1.28;Q1;164;313;789;14065;2933;716;3.55;44.94;United Kingdom;Oxford University Press;1981-ongoing;Toxicology (Q1)
89;22378;Vascular Pharmacology;journal;15371891;1.277;Q1;86;82;299;5458;1085;293;3.31;66.56;Netherlands;Elsevier BV;2002-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2); Physiology (Q2)"
90;23053;Journal of Natural Products;journal;01633864, 15206025;1.271;Q1;124;349;1250;12487;5112;1218;4.36;35.78;United States;American Chemical Society;1949, 1971, 1973, 1978-ongoing;"Analytical Chemistry (Q1); Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
91;21226;Drug Metabolism and Disposition;journal;00909556, 1521009X;1.267;Q1;161;207;626;9292;2205;589;3.4;44.89;United States;American Society for Pharmacology and Experimental Therapeutics;1973-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q1)"
92;7000153203;Journal of Studies on Alcohol and Drugs;journal;19371888, 19384114;1.264;Q1;116;127;372;3597;895;321;2.55;28.32;United States;Center of Alcohol Studies, Rutgers, The State University of New Jersey;2007-ongoing;"Health (social science) (Q1); Psychiatry and Mental Health (Q1); Toxicology (Q1)"
93;24032;Reviews of Physiology Biochemistry and Pharmacology;book series;03034240;1.261;Q1;58;7;21;1274;106;9;9.56;182.00;Germany;Springer Verlag;1974-2008, 2012-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Biochemistry (Q2); Physiology (Q2); Physiology (medical) (Q2)"
94;21100214102;Frontiers in Pharmacology;journal;16639812;1.256;Q1;62;1374;1781;89244;6933;1679;3.86;64.95;Switzerland;Frontiers Media S.A.;2010-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
95;16088;Journal of Nanobiotechnology;journal;14773155;1.255;Q1;57;105;267;6176;1425;260;5.21;58.82;United Kingdom;BioMed Central;2003-ongoing;"Applied Microbiology and Biotechnology (Q1); Bioengineering (Q1); Biomedical Engineering (Q1); Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1); Molecular Medicine (Q2); Nanoscience and Nanotechnology (Q2)"
96;28792;Cancer Biology and Therapy;journal;15384047;1.24;Q1;101;157;488;5492;1494;467;2.83;34.98;United States;Landes Bioscience;2002-ongoing;"Pharmacology (Q1); Cancer Research (Q2); Molecular Medicine (Q2); Oncology (Q2)"
97;21100258853;F1000Research;journal;20461402;1.235;Q1;32;702;1787;30157;4183;1659;2.64;42.96;United Kingdom;F1000 Research Ltd.;2012-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q1); Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Immunology and Microbiology (miscellaneous)  (Q2)"
98;21100219314;Applied and Translational Genomics;journal;22120661;1.231;Q1;13;0;73;0;195;59;4.07;0.00;Netherlands;Elsevier BV;2012-ongoing;"Biotechnology (Q1); Pharmaceutical Science (Q1); Molecular Biology (Q2)"
99;21455;Progress in Medicinal Chemistry;book series;00796468;1.23;Q1;33;6;17;1127;46;4;4.75;187.83;Netherlands;Elsevier BV;1961-1963, 1965, 1967, 1969-ongoing;"Pharmacology (Q1); Molecular Medicine (Q2)"
100;19403;Acta Pharmacologica Sinica;journal;16714083, 17457254;1.224;Q1;78;238;474;12536;1836;461;3.84;52.67;United States;Nature Publishing Group;1980-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
101;19700173005;Cancer Nanotechnology;journal;18686958, 18686966;1.22;Q1;19;11;25;564;125;21;6.39;51.27;United States;Springer Science + Business Media;2010-ongoing;"Biomedical Engineering (Q1); Pharmaceutical Science (Q1); Physical and Theoretical Chemistry (Q1); Oncology (Q2)"
102;17464;European Journal of Medicinal Chemistry;journal;02235234;1.21;Q1;135;1004;2391;55504;12261;2377;4.94;55.28;Netherlands;Elsevier BV;1974-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmacology (Q1)"
103;17700156714;Pharmaceuticals;journal;14248247;1.209;Q1;44;126;216;10718;820;203;3.85;85.06;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2009-ongoing;"Pharmaceutical Science (Q1); Molecular Medicine (Q2)"
104;19700177127;ACS Medicinal Chemistry Letters;journal;19485875;1.202;Q1;52;246;678;6280;2379;645;3.75;25.53;United States;American Chemical Society;2010-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2)"
105;29712;Clinical Therapeutics;journal;01492918;1.201;Q1;123;219;756;7624;1952;658;2.82;34.81;United States;Elsevier Inc.;1977-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1)"
106;29097;Cancer Chemotherapy and Pharmacology;journal;03445704;1.199;Q1;100;234;837;7689;2474;799;3.2;32.86;Germany;Springer Verlag;1978-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Toxicology (Q1); Cancer Research (Q2); Oncology (Q2)"
107;4400151701;Journal of Exposure Science and Environmental Epidemiology;journal;1559064X, 15590631;1.177;Q1;81;111;247;4688;782;237;3.16;42.23;United Kingdom;Nature Publishing Group;2006-ongoing;"Pollution (Q1); Public Health, Environmental and Occupational Health (Q1); Toxicology (Q1); Epidemiology (Q2)"
108;25222;Toxicology and Applied Pharmacology;journal;10960333, 0041008X;1.165;Q1;153;340;850;18289;3329;835;3.74;53.79;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q1); Toxicology (Q1)"
109;18966;Mutagenesis;journal;02678357, 14643804;1.164;Q1;82;44;223;1663;728;217;2.99;37.80;United Kingdom;Oxford University Press;1986-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1); Genetics (Q2); Genetics (clinical) (Q2)"
110;20578;Journal of Food and Drug Analysis;journal;10219498;1.16;Q1;41;167;318;7019;1412;312;4.22;42.03;Taiwan;Elsevier Taiwan LLC;1994-ongoing;"Food Science (Q1); Pharmacology (Q1)"
111;24649;Chemical Research in Toxicology;journal;15205010, 0893228X;1.149;Q1;144;169;651;7395;2227;632;3.3;43.76;United States;American Chemical Society;1988-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
112;4000148019;AAPS Journal;journal;15507416;1.146;Q1;96;112;480;5419;1853;457;3.43;48.38;United States;Springer New York;1999-ongoing;Pharmaceutical Science (Q1)
113;21100370879;Journal of managed care & specialty pharmacy;journal;23761032, 23760540;1.145;Q1;55;145;416;3855;952;384;2.26;26.59;United States;Academy of Managed Care Pharmacy (AMCP);2014-ongoing;"Health Policy (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1)"
114;22454;International Journal of Pharmaceutics;journal;03785173;1.135;Q1;190;796;2635;41571;11402;2594;4.32;52.22;Netherlands;Elsevier BV;1978-ongoing;Pharmaceutical Science (Q1)
115;22477;Investigational New Drugs;journal;01676997, 15730646;1.135;Q1;80;196;331;5912;943;322;2.61;30.16;Netherlands;Kluwer Academic Publishers;1983-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Oncology (Q2)"
116;13250;Expert Opinion on Biological Therapy;journal;14712598;1.133;Q1;75;158;472;11184;1537;436;3.54;70.78;United Kingdom;Taylor & Francis;2001-ongoing;"Clinical Biochemistry (Q1); Drug Discovery (Q1); Pharmacology (Q1)"
117;21100197941;International Journal for Parasitology: Drugs and Drug Resistance;journal;22113207;1.123;Q1;27;69;114;3742;397;110;3.02;54.23;Netherlands;Elsevier BV;2011-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Infectious Diseases (Q2); Parasitology (Q2)"
118;11700154316;CNS Neuroscience and Therapeutics;journal;17555949, 17555930;1.122;Q1;59;143;356;7832;1031;292;3.46;54.77;United States;Wiley-Blackwell;2008-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1); Physiology (medical) (Q2)"
119;21100469670;Antibiotics;journal;20796382;1.121;Q1;20;109;114;7069;366;111;3.03;64.85;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2014-ongoing;"Pharmacology (medical) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Infectious Diseases (Q2); Microbiology (Q2); Microbiology (medical) (Q2)"
120;19700174891;Perspectives in Medicinal Chemistry;journal;1177391X;1.113;Q1;13;0;5;0;35;5;11;0.00;New Zealand;Libertas Academica;2008-2011, 2014-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
121;7700153108;International journal of nanomedicine;journal;11782013, 11769114;1.098;Q1;100;625;1727;30893;8208;1697;4.54;49.43;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Bioengineering (Q1); Biomaterials (Q1); Biophysics (Q1); Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Nanoscience and Nanotechnology (Q2)"
122;21168;Pharmacogenomics Journal;journal;1470269X, 14731150;1.096;Q1;78;104;240;4911;805;225;3.56;47.22;United Kingdom;Nature Publishing Group;2001-ongoing;"Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
123;21123;Pharmaceutical Research;journal;07248741, 1573904X;1.093;Q1;191;249;815;11389;3154;794;3.98;45.74;United States;Kluwer Academic/Plenum Publishers;1984-ongoing;"Biotechnology (Q1); Organic Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1); Molecular Medicine (Q2)"
124;19700188360;Pharmaceutics;journal;19994923;1.091;Q1;32;287;130;18998;588;124;4.74;66.20;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;Pharmaceutical Science (Q1)
125;19700201201;EPMA Journal;journal;18785077, 18785085;1.085;Q1;26;34;88;2395;372;84;4.8;70.44;United Kingdom;BioMed Central;2010-ongoing;"Biochemistry (medical) (Q1); Drug Discovery (Q1); Health Policy (Q1)"
126;25125;Journal of Analytical Toxicology;journal;01464760;1.078;Q1;69;95;340;2119;1000;309;3.33;22.31;United States;Perston Publications, Inc.;1977-ongoing;"Analytical Chemistry (Q1); Chemical Health and Safety (Q1); Environmental Chemistry (Q1); Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
127;21351;Expert Opinion on Investigational Drugs;journal;13543784;1.076;Q1;94;99;403;7299;1254;378;3.7;73.73;United Kingdom;Taylor & Francis;1994-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
128;4700152903;Forensic Toxicology;journal;18608965, 18608973;1.071;Q1;30;58;128;1660;376;121;2.54;28.62;Germany;Springer Verlag;2006-ongoing;"Biochemistry (medical) (Q1); Pathology and Forensic Medicine (Q1); Toxicology (Q1)"
129;4200151509;Molecular Diagnosis and Therapy;journal;11771062;1.069;Q1;34;68;171;5344;480;163;3.18;78.59;United Kingdom;Adis International Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Genetics (Q2); Molecular Medicine (Q2)"
130;14144;Experimental and Clinical Psychopharmacology;journal;10641297;1.05;Q1;82;68;159;3464;397;157;1.98;50.94;United States;American Psychological Association;1993-ongoing;"Pharmacology (Q1); Pharmacology (medical) (Q1); Psychiatry and Mental Health (Q1)"
131;21326;European Journal of Clinical Pharmacology;journal;00316970, 14321041;1.044;Q1;99;205;573;6822;1543;497;2.88;33.28;Germany;Springer Verlag;1968-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)"
132;21100825823;Pharmacology Research and Perspectives;journal;20521707;1.042;Q1;20;71;264;2645;745;257;2.58;37.25;United Kingdom;Wiley-Blackwell Publishing Ltd;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Neurology (Q2)"
133;23079;Journal of Pharmaceutical Sciences;journal;00223549;1.035;Q1;159;351;1291;14967;4452;1213;3.3;42.64;United States;Elsevier Inc.;1961-ongoing;Pharmaceutical Science (Q1)
134;21100209501;Statistics in Biopharmaceutical Research;journal;19466315;1.033;Q1;11;40;125;924;120;113;0.94;23.10;United Kingdom;Taylor and Francis Inc.;2011-ongoing;"Pharmaceutical Science (Q1); Statistics and Probability (Q2)"
135;18073;NeuroToxicology;journal;0161813X;1.032;Q1;102;181;476;10745;1463;436;3.2;59.36;Netherlands;Elsevier BV;1979-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
136;19700188352;Toxins;journal;20726651;1.029;Q1;56;549;1127;30542;4067;1086;3.76;55.63;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2010-ongoing;"Health, Toxicology and Mutagenesis (Q1); Toxicology (Q1)"
137;25219;Toxicology;journal;0300483X;1.025;Q1;143;142;515;7838;1799;492;3.53;55.20;Netherlands;Elsevier BV;1959, 1973-ongoing;Toxicology (Q1)
138;17067;Phytomedicine;journal;09447113;1.024;Q1;105;285;539;12156;2191;526;4.11;42.65;Netherlands;Elsevier BV;1994-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q1); Molecular Medicine (Q2)"
139;21100829975;Clinical and Experimental Vaccine Research;journal;2287366X, 22873651;1.022;Q1;5;18;21;847;69;19;3.63;47.06;South Korea;Korean Vaccine Society;2017-ongoing;"Pharmacology (Q1); Public Health, Environmental and Occupational Health (Q1); Immunology and Allergy (Q2); Infectious Diseases (Q2)"
140;21353;Expert Opinion on Therapeutic Patents;journal;13543776;1.018;Q1;61;79;333;6056;1100;320;3.75;76.66;United Kingdom;Taylor & Francis;1991-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q1)"
141;20473;Life Sciences;journal;00243205;1.017;Q1;150;663;1215;36910;4105;1198;3.53;55.67;Netherlands;Elsevier BV;1962-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2)"
142;22072;Current Gene Therapy;journal;15665232;1.008;Q1;65;44;141;3257;315;128;2.16;74.02;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2); Molecular Biology (Q3)"
143;23015;Journal of Ethnopharmacology;journal;03788741;1.004;Q1;170;518;1869;32098;6839;1838;3.52;61.97;Netherlands;Elsevier BV;1979-ongoing;"Drug Discovery (Q1); Pharmacology (Q1)"
144;21333;European Journal of Pharmacology;journal;00142999;1.001;Q1;167;565;1900;29122;6143;1870;3.24;51.54;Netherlands;Elsevier BV;1967-ongoing;Pharmacology (Q1)
145;19700174905;Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy;journal;11787007;0.997;Q1;35;92;154;4144;527;152;3.32;45.04;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Pharmacology (Q1); Internal Medicine (Q2)"
146;21100200427;Human Vaccines and Immunotherapeutics;journal;21645515, 2164554X;0.989;Q2;43;438;1302;16533;2853;1026;2.85;37.75;United States;Landes Bioscience;2012-ongoing;"Medicine (miscellaneous) (Q1); Immunology (Q2); Immunology and Allergy (Q2); Pharmacology (Q2)"
147;17595;Journal of Biomolecular Screening;journal;10870571;0.989;Q1;69;0;257;0;619;249;2.37;0.00;United States;Sage Science Press;1996-ongoing;"Analytical Chemistry (Q1); Biotechnology (Q1); Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
148;25176;Regulatory Toxicology and Pharmacology;journal;02732300, 10960295;0.987;Q1;90;271;801;13180;3003;692;3.79;48.63;United States;Elsevier Inc.;1981-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
149;19700175230;Drug Design, Development and Therapy;journal;11778881;0.986;Q1;48;383;1239;16781;4032;1192;3.15;43.81;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Drug Discovery (Q1); Pharmaceutical Science (Q1); Pharmacology (Q2)"
150;11700154735;Journal of Aerosol Medicine and Pulmonary Drug Delivery;journal;19412711;0.985;Q1;61;44;138;1430;430;131;3.04;32.50;United States;Mary Ann Liebert Inc.;2008-ongoing;"Pharmaceutical Science (Q1); Pharmacology (medical) (Q2); Pulmonary and Respiratory Medicine (Q2)"
151;21350;Expert Opinion on Emerging Drugs;journal;14728214, 17447623;0.977;Q2;43;29;117;2879;342;108;3.03;99.28;United Kingdom;Taylor & Francis;2000-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
152;25240;Toxicology Letters;journal;03784274;0.971;Q1;129;372;785;17622;2628;742;3.39;47.37;Netherlands;Elsevier BV;1977-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1)"
153;22410;Inflammation Research;journal;1420908X, 10233830;0.97;Q2;82;99;291;5201;854;288;3.01;52.54;Switzerland;Birkhauser Verlag;1995-ongoing;"Pharmacology (Q2); Immunology (Q3)"
154;19700175029;Pharmacogenomics and Personalized Medicine;journal;11787066;0.965;Q2;22;22;61;1087;192;58;3.3;49.41;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
155;19700174918;Clinical and Translational Science;journal;17528062, 17528054;0.955;Q1;35;78;239;2565;561;211;3.75;32.88;United States;Wiley-Blackwell;2008-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q2)"
156;22983;Journal of Clinical Pharmacology;journal;00912700;0.954;Q2;106;211;568;7781;1445;522;2.88;36.88;United States;Wiley-Blackwell;1961-1964, 1970-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
157;22432;International Immunopharmacology;journal;15675769;0.953;Q2;98;508;1280;22224;4244;1255;3.38;43.75;Netherlands;Elsevier BV;2001-ongoing;"Immunology and Allergy (Q2); Pharmacology (Q2); Immunology (Q3)"
158;19034;Microbial Drug Resistance;journal;10766294;0.946;Q2;62;197;325;7138;788;323;2.54;36.23;United States;Mary Ann Liebert Inc.;1995-ongoing;"Medicine (miscellaneous) (Q1); Microbiology (Q2); Microbiology (medical) (Q2); Pharmacology (Q2); Immunology (Q3)"
159;21207;Drug Discovery Today: Technologies;journal;17406749;0.945;Q1;41;43;105;2480;279;92;3.53;57.67;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q1); Biotechnology (Q2); Molecular Medicine (Q2)"
160;12584;Drug Metabolism Reviews;journal;10979883, 03602532;0.944;Q1;89;25;89;3488;363;89;4.02;139.52;United States;Marcel Dekker Inc.;1972-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2)"
161;14500154702;Journal of Cardiovascular Translational Research;journal;19375395, 19375387;0.943;Q1;44;73;171;2569;353;156;2.48;35.19;United States;Springer New York LLC;2008-ongoing;"Pharmaceutical Science (Q1); Cardiology and Cardiovascular Medicine (Q2); Genetics (Q2); Molecular Medicine (Q2); Genetics (clinical) (Q3)"
162;18071;Neurotoxicity Research;journal;10298428;0.941;Q1;65;160;279;10385;851;274;3.17;64.91;United States;Springer New York LLC;2001-ongoing;"Toxicology (Q1); Neuroscience (miscellaneous) (Q2)"
163;18800156730;Biomolecules and Therapeutics;journal;19769148, 20054483;0.939;Q1;26;74;240;4098;698;236;3.06;55.38;South Korea;Korean Society of Applied Pharmacology;2008-ongoing;"Drug Discovery (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
164;20770;Drug Delivery;journal;10717544;0.937;Q1;52;184;693;8390;2641;681;3.96;45.60;United Kingdom;Taylor & Francis;1993, 1995-ongoing;"Medicine (miscellaneous) (Q1); Pharmaceutical Science (Q1)"
165;21100781436;Journal of Experimental Pharmacology;journal;11791454;0.937;Q2;7;6;21;475;66;21;3;79.17;New Zealand;Dove Medical Press Ltd.;2010, 2013-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
166;23085;Journal of Pharmacological Sciences;journal;13478648, 13478613;0.935;Q2;74;135;352;4013;971;348;2.49;29.73;Netherlands;Elsevier BV;1996-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
167;21790;Antiviral Therapy;journal;13596535;0.931;Q2;78;99;298;2996;559;284;2.01;30.26;United Kingdom;International Medical Press;1996-ongoing;"Infectious Diseases (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
168;28620;Biomedicine and Pharmacotherapy;journal;07533322;0.931;Q2;78;1845;2650;94888;9986;2631;3.83;51.43;France;Elsevier Masson;1982-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
169;17700156705;Modern Trends in Pharmacopsychiatry;book series;16622685;0.926;Q2;10;0;26;0;61;24;2.33;0.00;Switzerland;Karger;2009-2010, 2013-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
170;24786;Alcohol and Alcoholism;journal;07350414, 14643502;0.925;Q1;89;114;307;3874;716;273;2.61;33.98;United Kingdom;Oxford University Press;1965-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q1); Psychiatry and Mental Health (Q2)"
171;21197;Pharmacology Biochemistry and Behavior;journal;00913057;0.924;Q1;126;119;459;8836;1307;451;2.8;74.25;United States;Elsevier Inc.;1973-ongoing;"Toxicology (Q1); Behavioral Neuroscience (Q2); Biochemistry (Q2); Clinical Biochemistry (Q2); Pharmacology (Q2); Biological Psychiatry (Q3)"
172;24652;Chemico-Biological Interactions;journal;00092797;0.923;Q2;108;300;952;15479;3237;933;3.45;51.60;Netherlands;Elsevier BV;1969-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
173;4700152278;Drugs in Context;journal;17404398, 17451981;0.921;Q2;12;46;43;3211;121;41;1.09;69.80;United Kingdom;BioExcel Publishing Ltd;2006-2008, 2012-ongoing;"Molecular Medicine (Q2); Pharmacology (Q2)"
174;23488;Current Medicinal Chemistry;journal;09298673;0.918;Q1;158;329;843;33139;2762;788;3.25;100.73;United Arab Emirates;Bentham Science Publishers;1994-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Biochemistry (Q2); Molecular Medicine (Q2); Pharmacology (Q2)"
175;25096;Food and Chemical Toxicology;journal;02786915;0.916;Q2;149;803;1234;43309;4668;1195;3.39;53.93;Netherlands;Elsevier BV;1982-ongoing;"Food Science (Q1); Medicine (miscellaneous) (Q1); Toxicology (Q2)"
176;19700174974;Future Medicinal Chemistry;journal;17568919, 17568927;0.916;Q1;54;214;516;11448;1510;450;3.04;53.50;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Drug Discovery (Q1); Molecular Medicine (Q2); Pharmacology (Q2)"
177;24028;Reproductive Toxicology;journal;08906238;0.911;Q2;99;143;534;8777;1508;503;3.02;61.38;Netherlands;Elsevier BV;1987-ongoing;Toxicology (Q2)
178;110174;Prostaglandins and Other Lipid Mediators;journal;10988823;0.909;Q2;67;63;170;3286;435;163;2.31;52.16;Netherlands;Elsevier BV;1996, 1998-ongoing;"Biochemistry (Q2); Pharmacology (Q2); Physiology (Q2); Cell Biology (Q3)"
179;24626;Cell Biology and Toxicology;journal;15736822, 07422091;0.908;Q2;56;44;107;2261;397;94;4.96;51.39;Netherlands;Kluwer Academic Publishers;1984-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2); Cell Biology (Q3)"
180;21100325142;Journal of Pharmaceutical Policy and Practice;journal;20523211;0.902;Q1;12;31;102;1155;172;92;1.94;37.26;United Kingdom;BioMed Central;2013-ongoing;"Health Policy (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)"
181;4700152856;Expert Opinion on Drug Metabolism and Toxicology;journal;17425255;0.896;Q2;72;117;413;10206;1266;382;3.59;87.23;United Kingdom;Informa Healthcare;2005-ongoing;"Medicine (miscellaneous) (Q1); Pharmacology (Q2); Toxicology (Q2)"
182;21100853016;Antibodies;journal;20734468;0.895;Q1;5;0;14;0;32;14;0.4;0.00;Switzerland;MDPI AG;2014-ongoing;"Drug Discovery (Q1); Immunology and Allergy (Q2); Immunology (Q3)"
183;25224;Toxicology in Vitro;journal;08872333;0.895;Q2;96;247;739;11909;2433;726;3.17;48.21;Netherlands;Elsevier BV;1987-ongoing;"Medicine (miscellaneous) (Q1); Toxicology (Q2)"
184;22411;Inflammopharmacology;journal;09254692, 15685608;0.894;Q2;45;183;134;7536;453;127;3.45;41.18;Switzerland;Birkhauser Verlag;1991-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Immunology (Q3)"
185;26767;Altex;journal;1868596X, 18688551;0.893;Q2;45;42;123;8;411;104;4.56;0.19;Germany;Spektrum Akademischer Verlag GmbH;2000-ongoing;"Medical Laboratory Technology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2)"
186;18075;Neurotoxicology and Teratology;journal;08920362;0.886;Q2;89;61;224;4011;704;205;3;65.75;Netherlands;Elsevier BV;1987-ongoing;"Toxicology (Q2); Cellular and Molecular Neuroscience (Q3); Developmental Neuroscience (Q3)"
187;16573;Phytotherapy Research;journal;10991573, 0951418X;0.884;Q2;112;245;674;13887;2431;662;3.88;56.68;United States;John Wiley & Sons Inc.;1987-ongoing;Pharmacology (Q2)
188;34645;Skin Pharmacology and Physiology;journal;16605527, 16605535;0.883;Q2;68;52;106;2194;284;103;2.46;42.19;Switzerland;S. Karger AG;2004-ongoing;"Dermatology (Q1); Medicine (miscellaneous) (Q1); Pharmacology (Q2); Physiology (Q2)"
189;21100853500;Clinical Cancer Drugs;journal;22126988, 2212697X;0.882;Q1;3;0;6;0;20;6;7;0.00;United Arab Emirates;Bentham Science Publishers;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Oncology (Q2); Cancer Research (Q3)"
190;21331;European Journal of Pharmaceutical Sciences;journal;09280987;0.882;Q1;119;494;1100;23691;4053;1086;3.66;47.96;Netherlands;Elsevier BV;1993-ongoing;Pharmaceutical Science (Q1)
191;4400151608;ChemMedChem;journal;18607187, 18607179;0.88;Q1;92;280;790;13607;1962;751;2.8;48.60;Germany;Wiley - V C H Verlag GmbbH & Co.;2006-ongoing;"Drug Discovery (Q1); Organic Chemistry (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
192;19400157146;Food Additives and Contaminants: Part B Surveillance;journal;19393210, 19393229;0.88;Q2;21;42;133;1491;336;132;2.4;35.50;United Kingdom;Taylor & Francis;2008-ongoing;"Food Science (Q1); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
193;12331;Current Topics in Medicinal Chemistry;journal;15680266;0.878;Q1;104;242;781;20855;2315;677;3.39;86.18;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Medicine (miscellaneous) (Q2)"
194;22982;Journal of Cardiovascular Pharmacology and Therapeutics;journal;10742484;0.877;Q2;44;70;183;3185;403;176;2.33;45.50;United States;SAGE Publications;1996-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
195;4700151922;Research in Social and Administrative Pharmacy;journal;15517411;0.876;Q1;37;255;338;8793;729;248;3.13;34.48;Netherlands;Elsevier BV;2005-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1)"
196;29311;Current Cancer Drug Targets;journal;15680096;0.875;Q1;85;87;230;7712;500;205;2.28;88.64;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q1); Oncology (Q2); Pharmacology (Q2); Cancer Research (Q3)"
197;21100218055;BMC pharmacology & toxicology;journal;20506511;0.87;Q2;23;88;188;2887;450;185;2.25;32.81;United Kingdom;BioMed Central;2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
198;21124;Pharmaceutical Statistics;journal;15391612, 15391604;0.868;Q2;33;65;160;1272;189;150;1.45;19.57;United States;John Wiley & Sons Inc.;2004-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Statistics and Probability (Q2)"
199;21352;Expert Opinion on Pharmacotherapy;journal;14656566;0.866;Q2;69;216;710;15021;1886;654;2.89;69.54;United Kingdom;Taylor & Francis;1999-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
200;25151;Journal of Toxicology and Environmental Health - Part A;journal;10872620, 15287394;0.858;Q2;80;103;360;5401;896;351;2.67;52.44;United Kingdom;Taylor & Francis;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
201;144790;Marine Drugs;journal;16603397;0.855;Q2;84;520;1011;26965;4612;1004;3.81;51.86;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);2005-ongoing;Drug Discovery (Q2)
202;21100804457;Current Opinion in Toxicology;journal;24682020;0.849;Q2;7;75;85;4599;195;78;2.5;61.32;Netherlands;Elsevier BV;2016-ongoing;Toxicology (Q2)
203;25171;Mycotoxin Research;journal;01787888;0.841;Q2;31;37;76;1402;282;75;3.78;37.89;Germany;Springer Verlag;1993-1995, 2008-ongoing;"Biotechnology (Q2); Toxicology (Q2); Microbiology (Q3)"
204;22575;Cardiovascular Toxicology;journal;15307905;0.837;Q2;47;78;147;3167;392;145;2.72;40.60;United States;Humana Press, Inc.;2001-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Toxicology (Q2); Molecular Biology (Q3)"
205;22981;Journal of Cardiovascular Pharmacology;journal;15334023, 01602446;0.837;Q2;91;73;391;2248;879;367;2.36;30.79;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
206;21264;Drugs in R and D;journal;11745886;0.833;Q2;39;37;139;1153;350;130;2.38;31.16;United Kingdom;Adis International Ltd.;1999, 2002-2008, 2010-ongoing;Pharmacology (Q2)
207;25126;Journal of Applied Toxicology;journal;10991263, 0260437X;0.829;Q2;76;142;476;8104;1492;470;3.14;57.07;United States;John Wiley & Sons Inc.;1981-ongoing;Toxicology (Q2)
208;19700182043;Drug Delivery and Translational Research;journal;21903948, 2190393X;0.827;Q1;27;153;202;8057;626;193;2.98;52.66;Germany;Springer verlag;2011-ongoing;Pharmaceutical Science (Q1)
209;20664;Current Drug Targets;journal;13894501;0.825;Q2;92;153;569;14478;1246;501;2.29;94.63;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
210;24785;Alcohol;journal;07418329;0.823;Q2;74;72;251;4337;582;242;1.98;60.24;Netherlands;Elsevier BV;1984-ongoing;"Health (social science) (Q1); Biochemistry (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Behavioral Neuroscience (Q3); Neurology (Q3)"
211;130063;Pharmacological Reports;journal;17341140, 22995684;0.807;Q2;71;163;578;7536;1685;565;2.72;46.23;Netherlands;Elsevier BV;1998-2002, 2005-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
212;21100793213;Current Pharmacology Reports;journal;2198641X;0.803;Q2;13;44;115;4228;297;115;2.19;96.09;Switzerland;Springer International Publishing AG;2015, 2017-ongoing;"Biochemistry (Q2); Drug Discovery (Q2); Pharmacology (Q2); Genetics (Q3)"
213;11700154733;Journal of Biomedical Nanotechnology;journal;15507033;0.796;Q1;64;191;492;11620;2310;489;5.28;60.84;United States;American Scientific Publishers;2007-ongoing;"Pharmaceutical Science (Q1); Bioengineering (Q2); Biomedical Engineering (Q2); Materials Science (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2)"
214;24619;Journal of Computer-Aided Molecular Design;journal;15734951, 0920654X;0.792;Q2;89;101;268;5442;780;263;3.22;53.88;Netherlands;Kluwer Academic Publishers;1987-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Physical and Theoretical Chemistry (Q2)"
215;25146;Journal of Pharmacological and Toxicological Methods;journal;10568719;0.791;Q2;64;72;248;2741;572;244;2.74;38.07;Netherlands;Elsevier BV;1992-2002, 2004-ongoing;"Pharmacology (Q2); Toxicology (Q2)"
216;23479;Journal of Physiology and Pharmacology;journal;08675910, 18991505;0.791;Q2;70;84;270;3529;636;270;2.24;42.01;Poland;Polish Physiological Society;1991-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3)"
217;23061;Journal of Pharmaceutical and Biomedical Analysis;journal;07317085;0.786;Q1;114;730;1761;28919;5519;1745;3;39.62;Netherlands;Elsevier BV;1983-ongoing;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2)"
218;23081;Journal of Pharmacokinetics and Pharmacodynamics;journal;15738744, 1567567X;0.783;Q2;54;62;144;2505;309;138;2.46;40.40;United States;Kluwer Academic/Plenum Publishers;1996-1999, 2001-ongoing;Pharmacology (Q2)
219;20049;Behavioural Pharmacology;journal;14735849, 09558810;0.782;Q2;76;79;244;5412;491;236;1.9;68.51;United States;Lippincott Williams & Wilkins Ltd.;1992-ongoing;"Pharmacology (Q2); Psychiatry and Mental Health (Q2)"
220;17605;Journal of Enzyme Inhibition and Medicinal Chemistry;journal;14756374, 14756366;0.781;Q2;61;164;603;7746;2396;598;4.31;47.23;United Kingdom;Taylor & Francis;1985-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
221;11900154314;Cardiovascular Therapeutics;journal;17555914, 17555922;0.78;Q2;39;61;182;2062;391;177;2.17;33.80;United States;Wiley-Blackwell;2008-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
222;21192;Drug Development Research;journal;02724391, 10982299;0.779;Q2;54;57;145;2608;345;138;1.93;45.75;United States;John Wiley & Sons Inc.;1981-ongoing;Drug Discovery (Q2)
223;21100197929;Toxicological Research;journal;19768257;0.778;Q2;20;33;127;1114;350;124;2.93;33.76;South Korea;Korean Association of Medical Journal Editors;2008-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
224;25093;Environmental Toxicology;journal;15227278, 15204081;0.776;Q2;69;132;543;6024;1536;540;2.83;45.64;United States;John Wiley & Sons Inc.;1980, 1999-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
225;19600166302;Current molecular pharmacology;journal;18744702;0.774;Q2;34;35;100;2857;162;84;1.3;81.63;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
226;25095;Environmental Toxicology and Pharmacology;journal;13826689;0.771;Q2;72;196;796;9598;2545;785;3.15;48.97;Netherlands;Elsevier BV;1996-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
227;21167;Pharmacogenomics;journal;14622416;0.768;Q2;83;136;528;7014;1167;498;2.17;51.57;United Kingdom;Ashley Publications Ltd.;2000-ongoing;"Pharmacology (Q2); Genetics (Q3); Molecular Medicine (Q3)"
228;18077;Fitoterapia;journal;0367326X;0.767;Q2;90;320;651;10163;1950;649;2.63;31.76;Netherlands;Elsevier BV;1948-1949, 1961, 1972-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
229;19700175143;Pharmacognosy Reviews;journal;09737847, 09762787;0.767;Q2;36;30;67;2310;232;65;3.57;77.00;India;Medknow Publications;2009-ongoing;"Complementary and Alternative Medicine (Q1); Plant Science (Q1); Drug Discovery (Q2); Pharmacology (Q2)"
230;9000153111;Comparative Biochemistry and Physiology, Part C;journal;15320456;0.766;Q2;99;89;307;5130;832;302;2.7;57.64;Netherlands;Elsevier BV;2000-ongoing;"Biochemistry (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2); Cell Biology (Q3); Physiology (Q3)"
231;19900192116;Journal of Pharmaceutical Analysis;journal;20951779;0.763;Q1;21;58;161;2060;668;161;4.84;35.52;China;Xi'an Jiaotong University;2014-ongoing;"Analytical Chemistry (Q1); Pharmaceutical Science (Q1); Pharmacy (Q1); Drug Discovery (Q2); Electrochemistry (Q2); Spectroscopy (Q2)"
232;10900153302;Biomarker Insights;journal;11772719;0.758;Q2;24;24;116;1491;233;115;1.9;62.13;New Zealand;Libertas Academica;2008-ongoing;"Biochemistry (medical) (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
233;23014;Journal of Drug Targeting;journal;10292330, 1061186X;0.758;Q1;80;105;272;7273;847;260;3.19;69.27;United Kingdom;Taylor & Francis;1986-1987, 1992-ongoing;Pharmaceutical Science (Q1)
234;21100873122;Journal of Research in Pharmacy Practice;journal;23199644, 2279042X;0.758;Q1;1;0;1;0;3;1;0;0.00;India;Wolters Kluwer Medknow Publications;2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacy (Q1); Pharmacology (medical) (Q2)"
235;26370;Molecules;journal;14203049;0.757;Q1;116;3422;5453;174400;17813;5374;3.01;50.96;Switzerland;Multidisciplinary Digital Publishing Institute (MDPI);1996-ongoing;"Chemistry (miscellaneous) (Q1); Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Physical and Theoretical Chemistry (Q2); Molecular Medicine (Q3)"
236;19700175819;Patient Preference and Adherence;journal;1177889X;0.757;Q1;37;265;654;10391;1414;632;2.17;39.21;New Zealand;Dove Medical Press Ltd;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Social Sciences (miscellaneous) (Q1); Health Policy (Q2); Medicine (miscellaneous) (Q2)"
237;21100238633;BioImpacts;journal;22285652, 22285660;0.752;Q1;24;34;94;1707;303;88;3.19;50.21;Iran;Tabriz University of Medical Sciences;2011-ongoing;"Pharmaceutical Science (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
238;25786;Bioorganic and Medicinal Chemistry;journal;14643391, 09680896;0.747;Q1;142;622;2129;26304;6033;2077;2.85;42.29;United Kingdom;Elsevier Ltd.;1993-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Biology (Q3); Molecular Medicine (Q3)"
239;4500151409;CNS and Neurological Disorders - Drug Targets;journal;18715273;0.747;Q2;78;85;437;6363;899;375;2.61;74.86;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Neuroscience (miscellaneous) (Q3)"
240;19700174958;Drug Testing and Analysis;journal;19427611, 19427603;0.747;Q1;44;207;482;6931;1312;437;3.1;33.48;United Kingdom;John Wiley & Sons Ltd.;2009-ongoing;"Pharmaceutical Science (Q1); Analytical Chemistry (Q2); Environmental Chemistry (Q2); Spectroscopy (Q2)"
241;19700182275;International Journal of Clinical Pharmacy;journal;22107711, 22107703;0.746;Q1;52;189;475;5779;843;443;1.85;30.58;Germany;Springer Verlag;2010-ongoing;"Pharmaceutical Science (Q1); Pharmacy (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2); Toxicology (Q2)"
242;20659;Critical Reviews in Therapeutic Drug Carrier Systems;journal;07434863;0.736;Q1;69;14;45;2732;137;45;2.83;195.14;United States;Begell House;1984-ongoing;"Pharmaceutical Science (Q1); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
243;10300153301;Expert Review of Clinical Pharmacology;journal;17512433;0.731;Q1;32;119;350;9352;841;317;2.58;78.59;United Kingdom;Taylor & Francis;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
244;24603;Archives of Environmental Contamination and Toxicology;journal;14320703, 00904341;0.73;Q2;98;116;364;6465;952;359;2.24;55.73;Germany;Springer Verlag;1973-ongoing;"Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Pollution (Q2); Toxicology (Q2)"
245;20047;Basic and Clinical Pharmacology and Toxicology;journal;17427835;0.728;Q2;80;210;475;8521;1062;441;2.29;40.58;United States;Wiley-Blackwell;2004-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Toxicology (Q2)"
246;19300156901;Dose-Response;journal;15593258;0.727;Q2;30;101;106;4812;304;95;2.68;47.64;United States;International Dose-Response Society;2008-ongoing;"Chemical Health and Safety (Q1); Health, Toxicology and Mutagenesis (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
247;21100830708;Toxics;journal;23056304;0.726;Q2;12;61;96;3609;272;91;2.61;59.16;Switzerland;MDPI AG;2017-ongoing;"Chemical Health and Safety (Q2); Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
248;4700152233;Therapeutics and Clinical Risk Management;journal;11766336;0.725;Q1;43;271;610;9947;1245;586;1.88;36.70;New Zealand;Dove Medical Press Ltd;2006-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Safety Research (Q1); Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2)"
249;25075;Ecotoxicology;journal;09639292, 15733017;0.723;Q2;81;129;510;7592;1239;505;2.44;58.85;Netherlands;Kluwer Academic Publishers;1992-ongoing;"Health, Toxicology and Mutagenesis (Q2); Management, Monitoring, Policy and Law (Q2); Medicine (miscellaneous) (Q2); Toxicology (Q2)"
250;4000152107;Journal of Venomous Animals and Toxins Including Tropical Diseases;journal;16789199;0.72;Q2;22;39;133;2104;350;126;2.97;53.95;United Kingdom;BioMed Central;2006-ongoing;"Animal Science and Zoology (Q1); Parasitology (Q2); Toxicology (Q2); Infectious Diseases (Q3)"
251;21100198011;Current Protocols in Pharmacology;journal;19348282, 19348290;0.719;Q2;22;15;51;885;103;51;1;59.00;United States;John Wiley and Sons Inc.;2001-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
252;23382;Clinical and Experimental Pharmacology and Physiology;journal;14401681, 03051870;0.717;Q2;95;168;479;6859;993;449;2.27;40.83;United Kingdom;Blackwell Publishing Inc.;1974-ongoing;"Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
253;21100241624;International Journal of Genomics;journal;2314436X, 23144378;0.714;Q1;17;72;203;3994;412;194;2.18;55.47;Egypt;Hindawi Publishing Corporation;2013-ongoing;"Pharmaceutical Science (Q1); Biochemistry (Q3); Genetics (Q3); Molecular Biology (Q3)"
254;10300153342;Journal of medical toxicology : official journal of the American College of Medical Toxicology;journal;15569039;0.713;Q2;41;47;210;1086;351;173;2.07;23.11;United States;Springer New York LLC;2005-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q2)"
255;21865;Fundamental and Clinical Pharmacology;journal;07673981;0.712;Q2;64;79;200;3336;460;197;2.19;42.23;United Kingdom;Blackwell Publishing Inc.;1987-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
256;23007;Journal of Clinical Pharmacy and Therapeutics;journal;13652710, 02694727;0.71;Q2;65;147;380;4025;757;360;2.27;27.38;United Kingdom;Blackwell Publishing Inc.;1976-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
257;25214;Toxicologic Pathology;journal;15331601, 01926233;0.71;Q2;96;105;326;4117;571;314;1.36;39.21;United States;SAGE Publications;1972-ongoing;"Pathology and Forensic Medicine (Q2); Toxicology (Q2); Cell Biology (Q3); Molecular Biology (Q3)"
258;26512;Tetrahedron;journal;00404020;0.709;Q2;209;841;2971;45264;7025;2915;2.46;53.82;United Kingdom;Elsevier Ltd.;1957-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
259;19700175119;Asian Journal of Pharmaceutical Sciences;journal;18180876;0.707;Q1;27;95;293;3722;795;283;2.27;39.18;China;Shenyang Pharmaceutical University;2009-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
260;21100811517;Birth Defects Research;journal;24721727;0.706;Q2;7;145;139;6047;225;123;1.83;41.70;United Kingdom;John Wiley and Sons Ltd;2017-ongoing;"Health, Toxicology and Mutagenesis (Q2); Pediatrics, Perinatology and Child Health (Q2); Toxicology (Q2); Developmental Biology (Q3); Embryology (Q3)"
261;20682;Current Pharmaceutical Design;journal;13816128;0.703;Q2;140;450;1812;39688;4382;1662;2.43;88.20;United Arab Emirates;Bentham Science Publishers;1995-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
262;21100788810;Chemotherapy Research and Practice;journal;20902115, 20902107;0.699;Q1;5;0;1;0;7;1;0;0.00;United States;Hindawi Limited;2011, 2014-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Oncology (Q3)"
263;25789;Bioorganic Chemistry;journal;00452068, 10902120;0.697;Q2;50;369;383;15079;1473;382;3.94;40.86;United States;Elsevier Inc.;1971-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3)"
264;25788;Bioorganic and Medicinal Chemistry Letters;journal;14643405, 0960894X;0.696;Q1;133;701;3250;21128;8093;3217;2.55;30.14;United Kingdom;Elsevier Ltd.;1991-ongoing;"Pharmaceutical Science (Q1); Clinical Biochemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3)"
265;11300153402;Biomarkers in Medicine;journal;17520363, 17520371;0.69;Q2;37;134;380;6120;702;347;2.09;45.67;United Kingdom;Future Medicine Ltd.;2008-ongoing;"Biochemistry (medical) (Q2); Clinical Biochemistry (Q2); Drug Discovery (Q2)"
266;21100225613;Human gene therapy methods;journal;19466536, 19466544;0.688;Q2;20;25;86;881;170;81;1.96;35.24;United States;Mary Ann Liebert Inc.;2012-ongoing;"Applied Microbiology and Biotechnology (Q2); Pharmacology (Q2); Genetics (Q3); Genetics (clinical) (Q3); Molecular Medicine (Q3)"
267;19984;Assay and Drug Development Technologies;journal;1540658X;0.687;Q2;52;42;164;1491;249;129;1.74;35.50;United States;Mary Ann Liebert Inc.;2002-ongoing;"Drug Discovery (Q2); Molecular Medicine (Q3)"
268;28727;Anti-Cancer Drugs;journal;09594973, 14735741;0.684;Q2;88;125;394;4172;786;388;1.88;33.38;United States;Lippincott Williams & Wilkins Ltd.;1990-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2); Cancer Research (Q3); Oncology (Q3)"
269;20427;Naunyn-Schmiedeberg's Archives of Pharmacology;journal;00281298;0.682;Q2;83;129;373;6403;775;356;2.08;49.64;Germany;Springer Verlag;1969-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
270;18500157900;Food Additives and Contaminants - Part A Chemistry, Analysis, Control, Exposure and Risk Assessment;journal;19440057, 19440049;0.675;Q2;60;227;616;8112;1385;600;2.06;35.74;United States;Taylor and Francis;2008-ongoing;"Chemistry (miscellaneous) (Q2); Food Science (Q2); Health, Toxicology and Mutagenesis (Q2); Medicine (miscellaneous) (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q2)"
271;21100367469;Toxicology Reports;journal;22147500;0.674;Q3;21;153;355;7255;963;349;2.63;47.42;Ireland;Elsevier Scientific Publishers Ireland;2014-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
272;19958;Archives of Pharmacal Research;journal;02536269;0.673;Q2;75;124;568;6626;1358;550;2.46;53.44;South Korea;Pharmaceutical Society of Korea;1978-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3)"
273;19700194010;MedChemComm;journal;20402503, 20402511;0.673;Q1;44;209;760;9600;1697;717;2.41;45.93;United Kingdom;Royal Society of Chemistry;2010-ongoing;"Pharmaceutical Science (Q1); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
274;22205;Saudi Pharmaceutical Journal;journal;13190164;0.67;Q1;36;163;368;6375;1277;358;3.76;39.11;Saudi Arabia;King Saud University;1996-ongoing;"Pharmaceutical Science (Q1); Pharmacology (Q2)"
275;3500148011;Journal of Zhejiang University: Science B;journal;16731581;0.669;Q1;45;94;338;3482;697;306;2.03;37.04;China;Zhejiang University Press;2005-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Veterinary (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
276;15840;Journal of Antibiotics;journal;00218820;0.666;Q2;73;148;478;5005;1029;429;2.47;33.82;United Kingdom;Nature Publishing Group;1953-ongoing;"Drug Discovery (Q2); Pharmacology (Q2)"
277;21100239265;PharmaNutrition;journal;22134344;0.665;Q2;14;27;61;1485;166;59;3.4;55.00;Netherlands;Elsevier BV;2013-ongoing;"Food Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
278;25898;Journal of Peptide Science;journal;10752617, 10991387;0.662;Q2;60;68;303;2795;575;293;2.02;41.10;United States;John Wiley & Sons Inc.;1995-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Biology (Q3); Molecular Medicine (Q3); Structural Biology (Q3)"
279;20710;DARU, Journal of Pharmaceutical Sciences;journal;15608115;0.658;Q2;33;29;107;1128;316;98;2.72;38.90;United Kingdom;BioMed Central;2000-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
280;14487;Journal of Ocular Pharmacology and Therapeutics;journal;10807683;0.658;Q2;53;96;313;4071;529;283;1.84;42.41;United States;Mary Ann Liebert Inc.;1995-ongoing;"Ophthalmology (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
281;13845;Bulletin of Mathematical Biology;journal;00928240, 15229602;0.654;Q2;78;173;311;6796;525;293;1.73;39.28;United States;Springer New York LLC;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Computational Theory and Mathematics (Q2); Environmental Science (miscellaneous) (Q2); Mathematics (miscellaneous) (Q2); Pharmacology (Q2); Immunology (Q3); Neuroscience (miscellaneous) (Q3)"
282;23363;Canadian Journal of Physiology and Pharmacology;journal;00084212, 12057541;0.651;Q2;77;181;458;7702;935;443;1.83;42.55;Canada;NRC Research Press;1964-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q2); Physiology (Q3); Physiology (medical) (Q3)"
283;19900192900;Molecular Informatics;journal;18681751, 18681743;0.649;Q2;60;63;212;2468;463;199;2.54;39.17;Germany;Wiley - VCH Verlag GmbH & CO. KGaA;2010-ongoing;"Computer Science Applications (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Molecular Medicine (Q3); Structural Biology (Q3)"
284;25109;Inhalation Toxicology;journal;08958378, 10917691;0.643;Q3;77;57;223;3071;426;213;1.75;53.88;United Kingdom;Taylor & Francis;1989-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
285;21246;International Journal of Immunopathology and Pharmacology;journal;03946320;0.643;Q2;45;65;230;370;486;197;2.52;5.69;Italy;SAGE Publications Inc.;1989-ongoing;"Pharmacology (Q2); Immunology (Q3); Immunology and Allergy (Q3)"
286;14805;Steroids;journal;0039128X;0.641;Q2;95;150;532;6846;1320;517;2.17;45.64;Netherlands;Elsevier BV;1963-ongoing;"Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Endocrinology (Q3); Molecular Biology (Q3)"
287;19700200821;Therapeutic delivery;journal;20415990, 20416008;0.637;Q1;37;76;301;4360;597;258;2.12;57.37;United Kingdom;Future Medicine Ltd.;2010-ongoing;Pharmaceutical Science (Q1)
288;22319;Toxicon;journal;00410101;0.635;Q3;116;268;778;14233;1907;756;2.27;53.11;United Kingdom;Elsevier Ltd.;1962-ongoing;Toxicology (Q3)
289;19374;AAPS PharmSciTech;journal;15221059, 15309932;0.633;Q1;79;418;631;17876;1541;620;2.42;42.77;United States;American Association of Pharmaceutical Scientists;2000-ongoing;"Pharmaceutical Science (Q1); Agronomy and Crop Science (Q2); Aquatic Science (Q2); Drug Discovery (Q2); Ecology (Q2); Ecology, Evolution, Behavior and Systematics (Q2); Medicine (miscellaneous) (Q2)"
290;19444;American Journal of Pharmaceutical Education;journal;15536467, 00029459;0.63;Q1;52;147;572;2063;686;477;1.28;14.03;United States;American Association of Colleges of Pharmacy;1947-1948, 1973-1989, 1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Education (Q2); Medicine (miscellaneous) (Q2)"
291;21082;Pharmaceutical Biology;journal;13880209, 17445116;0.625;Q2;53;65;926;1782;2214;921;2.49;27.42;United Kingdom;Taylor & Francis;1961-1972, 1975-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
292;21100220486;Journal of Pharmaceutical Investigation;journal;20935552, 20936214;0.623;Q1;16;60;173;3389;411;172;3.22;56.48;Netherlands;Springer Netherlands;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmaceutical Science (Q2)"
293;26514;Tetrahedron Letters;journal;00404039;0.621;Q2;159;965;4113;39941;8749;4053;2.33;41.39;United Kingdom;Elsevier Ltd.;1959-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Biochemistry (Q3)"
294;21100455212;Biomedical Reports;journal;20499434, 20499442;0.617;Q1;15;154;425;6197;766;423;1.8;40.24;Greece;Spandidos Publications;2014-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2); Neuroscience (miscellaneous) (Q3)"
295;25241;Toxicology Mechanisms and Methods;journal;15376524, 15376516;0.617;Q3;35;89;246;3927;570;244;2.28;44.12;United Kingdom;Taylor & Francis;1991-ongoing;"Health, Toxicology and Mutagenesis (Q2); Toxicology (Q3)"
296;19447;Journal of the American Pharmacists Association : JAPhA;journal;15443191, 15443450;0.613;Q2;58;145;448;2896;635;387;1.68;19.97;United States;Elsevier Inc.;2003-ongoing;"Pharmacology (nursing) (Q1); Pharmacy (Q1); Pharmacology (Q2)"
297;22299;Therapeutic Drug Monitoring;journal;15363694, 01634356;0.613;Q2;87;89;355;1228;663;328;2;13.80;United States;Lippincott Williams & Wilkins Ltd.;1979-ongoing;"Pharmacology (Q2); Pharmacology (medical) (Q2)"
298;144956;Drug Metabolism and Pharmacokinetics;journal;13474367, 18800920;0.612;Q2;58;41;175;1617;354;167;1.83;39.44;United Kingdom;Elsevier Limited;2004-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q2); Pharmacology (medical) (Q2)"
299;19700170617;EXCLI Journal;journal;16112156;0.612;Q2;24;88;298;4146;636;251;2.01;47.11;Germany;University of Mainz;2009-ongoing;"Animal Science and Zoology (Q2); Drug Discovery (Q2); Pharmacology (Q2); Molecular Medicine (Q3)"
300;19700188217;Bioanalysis;journal;17576180, 17576199;0.609;Q1;51;188;712;6011;1238;619;1.99;31.97;United Kingdom;Future Medicine Ltd.;2009-ongoing;"Medical Laboratory Technology (Q1); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Analytical Chemistry (Q2); Medicine (miscellaneous) (Q2); Clinical Biochemistry (Q3)"
301;24797;Mini-Reviews in Medicinal Chemistry;journal;13895575;0.609;Q2;79;277;432;15824;972;384;2.51;57.13;United Arab Emirates;Bentham Science Publishers;2001-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q2)"
302;16067;Reading Teacher;journal;00340561;0.609;Q2;44;123;297;2940;261;256;0.92;23.90;United States;Wiley-Blackwell;1995-ongoing;"Language and Linguistics (Q1); Linguistics and Language (Q1); Pharmacology (Q2); Pharmacology (medical) (Q2)"
303;21190;Drug Development and Industrial Pharmacy;journal;03639045, 15205762;0.608;Q2;78;229;667;9545;1525;660;2.36;41.68;United States;Marcel Dekker Inc.;1974, 1976-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Pharmacology (Q2)"
304;5900153312;Recent Patents on Cardiovascular Drug Discovery;journal;15748901;0.608;Q2;25;0;8;0;12;7;0;0.00;United Arab Emirates;Bentham Science Publishers;2006-2015;"Cardiology and Cardiovascular Medicine (Q2); Drug Discovery (Q2); Pharmacology (medical) (Q2)"
305;23155;Current Vascular Pharmacology;journal;15701611;0.605;Q2;54;106;249;7332;458;201;2.34;69.17;United Arab Emirates;Bentham Science Publishers;2003-ongoing;"Cardiology and Cardiovascular Medicine (Q2); Pharmacology (Q2)"
306;28675;Brazilian Journal of Medical and Biological Research;journal;0100879X;0.604;Q1;79;191;469;5309;847;467;1.74;27.80;Brazil;Associacao Brasileira de Divulgacao Cientifica;1973-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biophysics (Q2); Medicine (miscellaneous) (Q2); Biochemistry (Q3); Immunology (Q3); Neuroscience (miscellaneous) (Q3); Physiology (Q3); Cell Biology (Q4)"
307;4000150314;Chemical Biology and Drug Design;journal;17470277;0.597;Q2;71;228;632;8675;1455;593;2.4;38.05;United Kingdom;Blackwell;2006-ongoing;"Drug Discovery (Q2); Organic Chemistry (Q2); Pharmacology (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
308;19443;American Journal of Health-System Pharmacy;journal;10792082;0.595;Q3;87;363;1148;5689;1162;757;1.39;15.67;United States;American Society of Health-System Pharmacists;1995-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
309;21099;Pharmaceutical Development and Technology;journal;10837450, 10979867;0.594;Q2;50;147;352;5675;741;344;2.15;38.61;United States;Marcel Dekker Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
310;18200156702;World Mycotoxin Journal;journal;18750710, 18750796;0.587;Q3;30;50;170;3506;388;166;2.25;70.12;Netherlands;Wageningen Academic Publishers;2009-ongoing;"Food Science (Q2); Public Health, Environmental and Occupational Health (Q2); Toxicology (Q3)"
311;22372;Immunopharmacology and Immunotoxicology;journal;15322513, 08923973;0.585;Q3;42;76;176;3217;382;171;2.18;42.33;United States;Marcel Dekker Inc.;1978-ongoing;"Medicine (miscellaneous) (Q2); Immunology (Q3); Immunology and Allergy (Q3); Pharmacology (Q3); Toxicology (Q3)"
312;21100232413;Advanced Pharmaceutical Bulletin;journal;22517308, 22285881;0.583;Q1;23;81;254;3488;651;248;2.31;43.06;Iran;Tabriz University of Medical Sciences, Faculty of Pharmacy;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmaceutical Science (Q2)"
313;19700174628;Iranian Journal of Basic Medical Sciences;journal;20083874, 20083866;0.583;Q2;27;180;546;7946;1117;540;1.96;44.14;Iran;University of Medical Sciences;2010-ongoing;"Biophysics (Q2); Drug Discovery (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Immunology and Microbiology (miscellaneous)  (Q3)"
314;22204;Journal of Drug Delivery Science and Technology;journal;17732247;0.583;Q2;38;343;465;15029;1195;459;2.69;43.82;France;Editions de Sante;2004-ongoing;Pharmaceutical Science (Q2)
315;21100241807;Artificial Cells, Nanomedicine and Biotechnology;journal;2169141X, 21691401;0.582;Q2;35;560;535;25295;1908;516;3.93;45.17;United States;Informa Healthcare;2013-ongoing;"Biomedical Engineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2)"
316;19900192163;Results in Pharma Sciences;journal;22112863;0.578;Q2;13;0;4;0;15;4;4.67;0.00;Netherlands;Elsevier BV;2011-ongoing;Pharmaceutical Science (Q2)
317;17700156777;Advances in Pharmacological Sciences;journal;16876342, 16876334;0.577;Q1;22;25;48;1307;122;48;2.26;52.28;Egypt;Hindawi Publishing Corporation;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Pharmacology (medical) (Q2); Molecular Medicine (Q3)"
318;19888;Medical Letter on Drugs and Therapeutics;journal;0025732X;0.577;Q3;18;120;388;986;174;200;1.09;8.22;United States;Medical Letter, Inc.;1965-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (medical) (Q2); Pharmacology (Q3)"
319;23035;Journal of Biopharmaceutical Statistics;journal;10543406, 15205711;0.575;Q3;43;88;258;2273;181;247;0.7;25.83;United States;Marcel Dekker Inc.;1991-ongoing;"Pharmacology (medical) (Q2); Pharmacology (Q3); Statistics and Probability (Q3)"
320;11000153762;Journal of Immunotoxicology;journal;1547691X, 15476901;0.574;Q3;32;21;173;750;319;171;1.88;35.71;United States;Taylor and Francis;2004-ongoing;"Immunology (Q3); Toxicology (Q3)"
321;21100262305;Clinical Pharmacology in Drug Development;journal;21607648, 2160763X;0.573;Q2;16;124;192;3021;328;175;2.2;24.36;United States;Wiley-Blackwell;2012-ongoing;"Pharmaceutical Science (Q2); Pharmacology (medical) (Q2)"
322;29634;Journal of Negative Results in BioMedicine;journal;14775751;0.573;Q1;19;0;58;0;74;58;1.39;0.00;United Kingdom;BioMed Central;2002-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q2); Medicine (miscellaneous) (Q2)"
323;25106;Human and Experimental Toxicology;journal;09603271;0.57;Q3;71;132;403;5977;819;389;2.08;45.28;United States;SAGE Publications;1981-ongoing;"Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
324;25149;Journal of Toxicological Sciences;journal;18803989, 03881350;0.57;Q3;44;74;260;2556;440;206;2.17;34.54;Japan;Japanese Society of Toxicological Sciences;1976-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
325;19600157763;Research in Pharmaceutical Sciences;journal;17355362, 17359414;0.57;Q1;20;52;183;1806;380;183;1.76;34.73;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
326;19700185200;Journal of Natural Medicines;journal;18610293;0.569;Q2;37;116;241;3201;491;234;2.15;27.59;Germany;Springer Verlag;2006-ongoing;"Complementary and Alternative Medicine (Q1); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2)"
327;25305;SAR and QSAR in Environmental Research;journal;1029046X, 1062936X;0.569;Q2;42;53;178;2710;403;175;2.18;51.13;United Kingdom;Taylor & Francis;1993-ongoing;"Bioengineering (Q2); Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Molecular Medicine (Q3)"
328;23102;Journal of Pharmacy and Pharmacology;journal;00223573;0.568;Q2;107;172;501;8196;1160;491;2.26;47.65;United States;Wiley-Blackwell;1949-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
329;20064;Biological and Pharmaceutical Bulletin;journal;13475215, 09186158;0.563;Q2;104;278;897;9314;1587;876;1.6;33.50;Japan;Pharmaceutical Society of Japan;1993-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
330;13671;Biologicals;journal;10958320, 10451056;0.563;Q3;51;64;254;2114;489;249;2.11;33.03;United States;Elsevier Inc.;1990-ongoing;"Applied Microbiology and Biotechnology (Q2); Bioengineering (Q2); Biotechnology (Q2); Medicine (miscellaneous) (Q2); Immunology and Microbiology (miscellaneous)  (Q3); Pharmacology (Q3)"
331;21744;Planta Medica;journal;14390221, 00320943;0.559;Q2;103;157;547;6699;1369;520;2.58;42.67;Germany;Georg Thieme Verlag;1961, 1965-ongoing;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Organic Chemistry (Q2); Pharmaceutical Science (Q2); Molecular Medicine (Q3); Pharmacology (Q3)"
332;145693;Canadian Pharmacists Journal;journal;17151635;0.555;Q2;18;66;186;1079;178;113;1.74;16.35;Canada;Canadian Pharmacists Association;2005-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
333;6400153120;Chinese Medicine;journal;17498546;0.555;Q3;34;61;120;3485;283;119;2.38;57.13;United Kingdom;BioMed Central;2006-ongoing;"Complementary and Alternative Medicine (Q1); Pharmacology (Q3)"
334;23173;Korean Journal of Physiology and Pharmacology;journal;12264512;0.554;Q3;23;73;229;3269;375;223;1.73;44.78;South Korea;Eui-Hak Publishing and Printing Co.;1997-ongoing;"Pharmacology (Q3); Physiology (Q3)"
335;16533;Phytochemical Analysis;journal;09580344, 10991565;0.553;Q2;63;64;160;2551;346;159;1.89;39.86;United States;John Wiley & Sons Inc.;1990-ongoing;"Complementary and Alternative Medicine (Q1); Analytical Chemistry (Q2); Drug Discovery (Q2); Food Science (Q2); Medicine (miscellaneous) (Q2); Plant Science (Q2); Biochemistry (Q3); Molecular Medicine (Q3)"
336;28794;Cancer Biotherapy and Radiopharmaceuticals;journal;10849785;0.545;Q3;55;61;159;2171;270;150;1.73;35.59;United States;Mary Ann Liebert Inc.;1996-ongoing;"Medicine (miscellaneous) (Q2); Radiology, Nuclear Medicine and Imaging (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (Q3)"
337;20663;Current Drug Metabolism;journal;13892002;0.544;Q3;97;117;261;12111;567;241;2.27;103.51;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Clinical Biochemistry (Q3); Pharmacology (Q3)"
338;13248;Experimental and Toxicologic Pathology;journal;09402993;0.541;Q3;58;0;206;0;426;203;2.08;0.00;Netherlands;Elsevier BV;1992-ongoing;"Medicine (miscellaneous) (Q2); Pathology and Forensic Medicine (Q2); Toxicology (Q3); Cell Biology (Q4)"
339;16319;IEEE Transactions on Nanobioscience;journal;15361241;0.541;Q2;55;68;330;2502;733;315;2.29;36.79;United States;Institute of Electrical and Electronics Engineers;2002-ongoing;"Bioengineering (Q2); Biomedical Engineering (Q2); Biotechnology (Q2); Computer Science Applications (Q2); Electrical and Electronic Engineering (Q2); Medicine (miscellaneous) (Q2); Nanoscience and Nanotechnology (Q2); Pharmaceutical Science (Q2)"
340;26568;International Journal of Cosmetic Science;journal;01425463, 14682494;0.541;Q2;53;68;256;2723;490;251;1.6;40.04;United Kingdom;Blackwell Publishing Inc.;1979-ongoing;"Chemistry (miscellaneous) (Q2); Dermatology (Q2); Drug Discovery (Q2); Pharmaceutical Science (Q2); Colloid and Surface Chemistry (Q3); Aging (Q4)"
341;23129;Journal of Veterinary Pharmacology and Therapeutics;journal;01407783, 13652885;0.54;Q3;54;127;273;4481;334;270;1.13;35.28;United Kingdom;Blackwell Publishing Inc.;1978-ongoing;"Veterinary (miscellaneous) (Q2); Pharmacology (Q3)"
342;23089;Journal of Pharmacy and Pharmaceutical Sciences;journal;14821826;0.539;Q2;69;45;139;1509;262;137;1.53;33.53;Canada;Canadian Society for Pharmaceutical Sciences;1998-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3)"
343;24624;Bulletin of Environmental Contamination and Toxicology;journal;00074861, 14320800;0.536;Q3;63;270;804;8197;1427;781;1.74;30.36;Germany;Springer Verlag;1966-ongoing;"Medicine (miscellaneous) (Q2); Pollution (Q2); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
344;14822;Xenobiotica;journal;00498254, 13665928;0.532;Q3;75;181;375;6624;665;366;1.77;36.60;United Kingdom;Taylor & Francis;1971-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Toxicology (Q3)"
345;12328;Current Therapeutic Research - Clinical and Experimental;journal;0011393X;0.531;Q3;34;15;56;373;85;49;1.97;24.87;United States;Elsevier Inc.;1959-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
346;5800173385;Recent Patents on Anti-Cancer Drug Discovery;journal;15748928;0.529;Q2;36;36;88;3586;184;82;2.09;99.61;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q2); Medicine (miscellaneous) (Q2); Cancer Research (Q3); Oncology (Q3); Pharmacology (medical) (Q3)"
347;29318;Anti-Cancer Agents in Medicinal Chemistry;journal;18715206, 18755992;0.528;Q3;82;67;511;4557;1022;480;2.01;68.01;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cancer Research (Q3); Molecular Medicine (Q3); Pharmacology (Q3)"
348;16948;Chirality;journal;1520636X, 08990042;0.522;Q2;73;137;341;5428;611;333;1.91;39.62;United States;John Wiley & Sons Inc.;1989-ongoing;"Analytical Chemistry (Q2); Drug Discovery (Q2); Spectroscopy (Q2); Catalysis (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
349;5800173383;Current Clinical Pharmacology;journal;15748847;0.522;Q2;33;30;111;1656;156;100;1.19;55.20;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
350;5400152628;Brazilian Journal of Pharmacognosy;journal;0102695X, 1981528X;0.521;Q2;37;110;332;4424;666;325;1.89;40.22;Brazil;Sociedade Brasileira de Farmacognosia;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
351;11400153330;Recent Patents on Endocrine, Metabolic and Immune Drug Discovery;journal;18722148;0.521;Q3;20;0;43;0;82;38;2.04;0.00;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Medicine (miscellaneous) (Q2); Biochemistry (medical) (Q3); Drug Discovery (Q3); Endocrinology, Diabetes and Metabolism (Q3); Immunology and Allergy (Q3)"
352;4700152701;Pharmacy Practice;journal;1885642X, 18863655;0.518;Q2;19;50;127;1635;203;121;1.49;32.70;Spain;Centro de Investigaciones y Publicaciones Farmaceuticas;2006-ongoing;"Pharmacy (Q1); Pharmaceutical Science (Q2)"
353;59665;Chinese Journal of Natural Medicines;journal;18755364, 20956975;0.515;Q3;27;101;346;3858;706;341;1.8;38.20;China;China Pharmaceutical University;2004-ongoing;"Complementary and Alternative Medicine (Q1); Medicine (miscellaneous) (Q2); Drug Discovery (Q3)"
354;19700175023;Journal of Toxicology;journal;16878205, 16878191;0.513;Q3;26;39;53;1989;128;53;2.24;51.00;Egypt;Hindawi Publishing Corporation;2010-ongoing;"Pharmacology (Q3); Toxicology (Q3)"
355;20634;Journal of Texture Studies;journal;00224901;0.512;Q2;48;77;167;2857;269;161;1.57;37.10;United States;Wiley-Blackwell;1969-ongoing;"Food Science (Q2); Pharmaceutical Science (Q2)"
356;20602;Clinical Neuropharmacology;journal;03625664;0.509;Q3;74;57;198;1269;277;179;1.43;22.26;United States;Lippincott Williams & Wilkins Ltd.;1982-ongoing;"Neurology (clinical) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
357;20627;Clinical Research and Regulatory Affairs;journal;15322521, 10601333;0.509;Q2;14;0;25;0;48;23;0.86;0.00;United States;Marcel Dekker Inc.;1983-1990, 1992-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
358;21100241601;Toxicology Research;journal;2045452X;0.509;Q3;24;115;385;6753;699;377;1.66;58.72;United Kingdom;Royal Society of Chemistry;2012-ongoing;"Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
359;19700174941;Pharmacognosy Research;journal;09748490, 09764836;0.502;Q3;25;70;222;2438;382;219;1.63;34.83;India;Medknow Publications;2010-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
360;4000151703;Core Evidence;journal;15551741, 1555175X;0.501;Q3;19;3;15;136;33;15;2.29;45.33;United States;Core Medical Pub;2005-ongoing;"Medicine (miscellaneous) (Q2); Reviews and References (medical) (Q2); Pharmacology (Q3)"
361;21100366771;Journal of Applied Research on Medicinal and Aromatic Plants;journal;22147861;0.5;Q3;11;48;120;2492;276;118;2.3;51.92;Germany;Elsevier GmbH;2014-ongoing;"Plant Science (Q2); Drug Discovery (Q3)"
362;19700188399;Current Protocols in Toxicology;journal;19349254, 19349262;0.498;Q3;18;21;55;329;76;55;1.3;15.67;United Kingdom;John Wiley & Sons Ltd.;2001-ongoing;"Medicine (miscellaneous) (Q2); Toxicology (Q3)"
363;5800228222;Journal of Pharmaceutical Innovation;journal;18725120;0.496;Q2;25;24;89;848;212;85;1.7;35.33;United States;Springer USA;2006-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
364;20545;PDA Journal of Pharmaceutical Science and Technology;journal;10797440;0.493;Q2;33;63;169;1108;161;148;1.07;17.59;United States;Parenteral Drug Association Inc;1994-ongoing;Pharmaceutical Science (Q2)
365;23039;Journal of Liposome Research;journal;08982104, 15322394;0.489;Q2;44;45;103;1933;211;100;2.12;42.96;United States;Marcel Dekker Inc.;1988-1990, 1992-ongoing;Pharmaceutical Science (Q2)
366;21328;European Journal of Drug Metabolism and Pharmacokinetics;journal;03787966;0.488;Q3;34;88;242;3465;365;233;1.59;39.38;France;Springer Paris;1976-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
367;22456;International Journal of Pharmacy Practice;journal;09617671;0.486;Q2;32;91;198;2644;230;164;1.31;29.05;United Kingdom;Wiley-Blackwell;1991-ongoing;"Health Policy (Q2); Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacy (Q2); Public Health, Environmental and Occupational Health (Q3)"
368;29053;Molecular Diversity;journal;1573501X, 13811991;0.482;Q3;54;103;233;5106;495;230;2.07;49.57;Netherlands;Kluwer Academic Publishers;1995-1998, 2000, 2003-ongoing;"Information Systems (Q2); Medicine (miscellaneous) (Q2); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Molecular Biology (Q4)"
369;21907;Journal of Anaesthesiology Clinical Pharmacology;journal;09709185;0.481;Q2;25;151;445;2292;372;255;1.25;15.18;India;Medknow Publications;1996-1999, 2002-ongoing;"Anesthesiology and Pain Medicine (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
370;18922;Journal of Gene Medicine;journal;1099498X, 15212254;0.48;Q3;87;48;103;2305;154;97;1.6;48.02;United States;John Wiley & Sons Inc.;1998-ongoing;"Drug Discovery (Q3); Genetics (Q3); Molecular Medicine (Q3); Genetics (clinical) (Q4); Molecular Biology (Q4)"
371;20766;Drug and Chemical Toxicology;journal;01480545, 15256014;0.479;Q3;38;160;198;6002;367;192;1.7;37.51;United States;Marcel Dekker Inc.;1977-ongoing;"Chemical Health and Safety (Q2); Medicine (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
372;19700180522;Molecular and Cellular Toxicology;journal;1738642X;0.477;Q2;18;50;152;2113;241;150;1.77;42.26;Germany;Springer Verlag;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Pathology and Forensic Medicine (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
373;19500157062;Current Cardiovascular Risk Reports;journal;19329563, 19329520;0.476;Q3;23;31;139;1841;104;138;0.63;59.39;United States;Current Medicine Group;2007-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
374;4700152603;Medicinal Chemistry;journal;15734064;0.475;Q3;39;81;266;3262;466;258;1.73;40.27;United Arab Emirates;Bentham Science Publishers;2005-ongoing;Drug Discovery (Q3)
375;4900153304;Archives of Environmental and Occupational Health;journal;19338244;0.472;Q3;58;76;159;2014;182;135;1.21;26.50;United States;Heldref Publications;2005-ongoing;"Environmental Science (miscellaneous) (Q2); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
376;20570;Chemotherapy;journal;00093157, 14219794;0.472;Q3;49;35;126;898;168;120;1.47;25.66;Switzerland;S. Karger AG;1963-ongoing;"Medicine (miscellaneous) (Q2); Drug Discovery (Q3); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
377;27087;American Journal of Therapeutics;journal;10752765, 15363686;0.465;Q3;55;156;634;1465;618;481;1.25;9.39;United States;Lippincott Williams & Wilkins Ltd.;1960-1961, 1996-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
378;15462;Biotechnology and Applied Biochemistry;journal;14708744, 08854513;0.464;Q3;62;110;312;4502;488;311;1.53;40.93;United States;Wiley-Blackwell;1986-ongoing;"Medicine (miscellaneous) (Q2); Process Chemistry and Technology (Q2); Applied Microbiology and Biotechnology (Q3); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Drug Discovery (Q3); Molecular Medicine (Q3)"
379;130089;Toxin Reviews;journal;15569543, 15569551;0.461;Q3;38;93;122;3137;292;108;3.42;33.73;United Kingdom;Taylor & Francis;1982-ongoing;Toxicology (Q3)
380;29947;Journal of Chemotherapy;journal;1120009X;0.458;Q3;45;60;233;1918;304;215;1.34;31.97;United Kingdom;Maney Publishing;1989-ongoing;"Medicine (miscellaneous) (Q2); Infectious Diseases (Q3); Oncology (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
381;20066;Biopharmaceutics and Drug Disposition;journal;1099081X, 01422782;0.456;Q2;54;48;153;1716;245;146;1.71;35.75;United States;John Wiley & Sons Inc.;1979-ongoing;"Medicine (miscellaneous) (Q2); Pharmaceutical Science (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
382;25223;Toxicology and Industrial Health;journal;07482337, 14770393;0.456;Q3;52;91;448;3820;728;415;1.91;41.98;United States;SAGE Publications;1985-ongoing;"Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
383;21100446418;Contemporary Clinical Trials Communications;journal;24518654;0.453;Q3;6;109;195;3785;189;191;1.01;34.72;United States;Elsevier Inc.;2015-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology (Q3)"
384;21100239606;Therapeutic Innovation and Regulatory Science;journal;21684790;0.453;Q2;12;169;328;4143;272;297;0.97;24.51;United States;SAGE Publications Inc.;1970, 1972, 1974-2006, 2008-2011, 2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3); Public Health, Environmental and Occupational Health (Q3)"
385;28636;Birth Defects Research Part B - Developmental and Reproductive Toxicology;journal;15429733, 15429741;0.449;Q3;54;0;47;0;67;46;1.81;0.00;United States;John Wiley & Sons Inc.;2003-ongoing;"Embryology (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3); Developmental Biology (Q4)"
386;21100212330;Drug discoveries & therapeutics;journal;1881784X, 18817831;0.444;Q2;19;30;140;0;227;138;1.11;0.00;Japan;International Advancement Center for Medicine & Health Research Co., Ltd. (IACMHR Co., Ltd.);2012-ongoing;"Medicine (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
387;23050;Journal of Microencapsulation;journal;02652048, 14645246;0.444;Q2;70;59;241;2610;472;239;2.05;44.24;United Kingdom;Taylor & Francis;1984-ongoing;"Pharmaceutical Science (Q2); Bioengineering (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3); Colloid and Surface Chemistry (Q4)"
388;21100470510;Drug Research;journal;21949379, 21949387;0.437;Q3;56;113;308;3330;484;287;1.76;29.47;Germany;Thieme;1972, 2013-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
389;21194;Pharmacology;journal;00317012, 14230313;0.437;Q3;54;67;247;2285;345;246;1.44;34.10;Switzerland;S. Karger AG;1968-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
390;23942;Biomedical Chromatography;journal;10990801, 02693879;0.436;Q3;58;312;751;9751;1234;738;1.73;31.25;United States;John Wiley & Sons Inc.;1986-ongoing;"Analytical Chemistry (Q2); Biochemistry (Q3); Clinical Biochemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Biology (Q4)"
391;22980;Journal of Basic and Clinical Physiology and Pharmacology;journal;21910286, 07926855;0.434;Q3;30;95;224;3671;371;218;1.69;38.64;Germany;Walter de Gruyter GmbH;1985-1988, 1990-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Physiology (Q4)"
392;130072;International Journal of Medicinal Mushrooms;journal;15219437;0.431;Q3;25;101;330;4016;477;328;1.39;39.76;United States;Begell House;2005-ongoing;"Applied Microbiology and Biotechnology (Q3); Drug Discovery (Q3); Pharmacology (Q3)"
393;5800173387;Reviews on Recent Clinical Trials;journal;15748871;0.427;Q3;30;46;136;2455;119;122;0.95;53.37;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
394;23489;Chemical Speciation and Bioavailability;journal;09542299;0.425;Q3;25;13;74;453;123;72;1.98;34.85;United Kingdom;Taylor & Francis;1989-ongoing;"Chemical Health and Safety (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q3)"
395;15581;Current Pharmaceutical Biotechnology;journal;13892010;0.42;Q2;73;111;419;8178;593;375;1.49;73.68;United Arab Emirates;Bentham Science Publishers;2000-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3)"
396;21100444313;Sustainable Chemistry and Pharmacy;journal;23525541;0.42;Q2;9;53;62;2170;144;54;2.64;40.94;Netherlands;Elsevier BV;2015-ongoing;"Pharmaceutical Science (Q2); Pollution (Q2); Environmental Chemistry (Q3); Management, Monitoring, Policy and Law (Q3)"
397;27210;In Vivo;journal;0258851X;0.419;Q3;54;235;428;7011;642;422;1.6;29.83;Greece;International Institute of Anticancer Research;1987-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
398;4700152769;Pharmacopeial Forum;journal;03634655;0.41;Q3;16;0;38;0;11;38;0.3;0.00;United States;Pharmacopeia;1996-1998, 2000-2017 (cancelled);"Drug Guides (Q2); Pharmacy (Q2); Pharmacology (Q3)"
399;24074;Helvetica Chimica Acta;journal;0018019X, 15222675;0.409;Q3;79;58;351;2764;387;345;1.33;47.66;United States;Wiley-Blackwell;1918-ongoing;"Biochemistry (Q3); Catalysis (Q3); Drug Discovery (Q3); Inorganic Chemistry (Q3); Organic Chemistry (Q3); Physical and Theoretical Chemistry (Q3)"
400;20580;Journal of Food Biochemistry;journal;01458884;0.408;Q3;40;236;309;10935;425;306;1.36;46.33;United States;Wiley-Blackwell;1977-ongoing;"Food Science (Q2); Biophysics (Q3); Pharmacology (Q3); Cell Biology (Q4)"
401;19200156706;Pharmacognosy Magazine;journal;09731296, 09764062;0.407;Q2;29;174;483;5756;711;481;1.33;33.08;India;Medknow Publications;2008-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
402;3200147837;Journal of Exercise Science and Fitness;journal;1728869X;0.405;Q2;17;22;47;669;51;47;0.93;30.41;Singapore;Elsevier (Singapore) Pte Ltd;2005-ongoing;"Pharmacology (nursing) (Q1); Pharmaceutical Science (Q2); Physical Therapy, Sports Therapy and Rehabilitation (Q3); Public Health, Environmental and Occupational Health (Q3); Sports Science (Q3)"
403;11400153335;Recent Patents on Inflammation and Allergy Drug Discovery;journal;1872213X;0.405;Q3;21;17;47;1568;71;43;2.07;92.24;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Drug Discovery (Q3); Immunology and Allergy (Q3); Medicine (miscellaneous) (Q3)"
404;21100788744;OpenNano;journal;23529520;0.404;Q2;4;7;12;333;25;12;2.08;47.57;United States;Elsevier Inc.;2016-ongoing;"Pharmaceutical Science (Q2); Biotechnology (Q3); Internal Medicine (Q3); Pharmacology (medical) (Q3)"
405;130025;Current Drug Delivery;journal;15672018;0.402;Q2;54;140;361;7726;536;339;1.44;55.19;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Pharmaceutical Science (Q2)
406;17700156313;Iranian Journal of Pharmaceutical Research;journal;17350328, 17266890;0.402;Q2;31;190;510;6889;760;497;1.25;36.26;Iran;Shaheed Behesti University of Medical Sciences and Health;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
407;19956;Archiv der Pharmazie;journal;15214184, 03656233;0.4;Q2;54;82;257;3766;560;251;2.11;45.93;United Kingdom;John Wiley & Sons Ltd.;1959-1965, 1972-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
408;21100798510;Journal of Intercultural Ethnopharmacology;journal;21468397;0.4;Q3;7;0;122;0;163;118;1.38;0.00;Turkey;Ejmanager LLC;2016-2017 (cancelled);"Complementary and Alternative Medicine (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
409;130047;Current Drug Discovery Technologies;journal;15701638;0.397;Q3;38;32;72;1739;128;70;1.2;54.34;United Arab Emirates;Bentham Science Publishers;2004-ongoing;Drug Discovery (Q3)
410;34545;Journal of Asian Natural Products Research;journal;10286020, 14772213;0.391;Q2;35;243;452;3349;542;423;1.24;13.78;United Kingdom;Taylor & Francis;1998-ongoing;"Complementary and Alternative Medicine (Q2); Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
411;25111;International Journal of Toxicology;journal;10915818, 1092874X;0.39;Q3;51;54;198;2366;237;181;1.29;43.81;United States;SAGE Publications;1982-ongoing;Toxicology (Q3)
412;22434;International Journal of Clinical Pharmacology and Therapeutics;journal;09461965;0.389;Q3;62;87;392;1993;398;381;1.04;22.91;Germany;Dustri-Verlag Dr. Karl Feistle;1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
413;26766;ATLA Alternatives to Laboratory Animals;journal;02611929;0.388;Q3;55;28;136;969;113;107;1.18;34.61;United Kingdom;Fund for the Replacement of Animals in Medical Experiments;1982, 1985-1986, 1988-1989, 1994-ongoing;"Medical Laboratory Technology (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q3)"
414;17500155003;Records of Natural Products;journal;13076167;0.386;Q3;24;58;262;2159;336;261;1.17;37.22;Turkey;ACG Publications;2009-ongoing;"Plant Science (Q2); Drug Discovery (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
415;23412;Journal of AOAC International;journal;10603271;0.38;Q3;79;246;680;4692;802;663;1.13;19.07;United States;AOAC International;1993-ongoing;"Agronomy and Crop Science (Q2); Analytical Chemistry (Q3); Environmental Chemistry (Q3); Food Science (Q3); Pharmacology (Q3)"
416;21256;Drugs of Today;journal;16993993, 16994019;0.379;Q3;46;55;177;2150;190;171;1.06;39.09;Spain;Prous Science;1968, 1978-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Pharmacology (medical) (Q3)"
417;5800173403;Recent Patents on Anti-Infective Drug Discovery;journal;1574891X;0.378;Q3;27;24;70;1462;71;55;1.14;60.92;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Infectious Diseases (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
418;130031;Journal of Toxicologic Pathology;journal;09149198;0.372;Q3;20;42;166;1749;140;119;1.24;41.64;Japan;Nihon Dokusei Byori Gakkai;1998-2002, 2004-ongoing;"Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
419;5800173386;Current Drug Safety;journal;15748863;0.371;Q3;31;40;133;1058;148;123;1.22;26.45;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3); Toxicology (Q3)"
420;24578;Mathematical Medicine and Biology;journal;14778599;0.37;Q3;40;27;68;1143;90;67;1.24;42.33;United Kingdom;Oxford University Press;1984-1995, 2003-ongoing;"Environmental Science (miscellaneous) (Q2); Applied Mathematics (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Modeling and Simulation (Q3); Neuroscience (miscellaneous) (Q3); Pharmacology (Q3); Immunology and Microbiology (miscellaneous)  (Q4)"
421;22393;Indian Journal of Pharmacology;journal;02537613, 19983751;0.369;Q3;52;55;421;1115;463;366;1.11;20.27;India;Medknow Publications;1978-1980, 1982, 1984-1986, 1994-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
422;21100218529;Value in Health Regional Issues;journal;22121099, 22121102;0.369;Q2;12;76;158;2671;144;144;1.11;35.14;United States;Elsevier USA;2012-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3)"
423;23453;Combinatorial Chemistry and High Throughput Screening;journal;13862073;0.367;Q3;59;94;290;2650;357;256;1.45;28.19;United Arab Emirates;Bentham Science Publishers;1998-ongoing;"Computer Science Applications (Q3); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Organic Chemistry (Q3)"
424;18384;Medicinal Chemistry Research;journal;10542523;0.366;Q2;38;227;929;8189;1563;915;1.72;36.07;United States;Birkhauser Boston;1994, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Organic Chemistry (Q3)"
425;19700174906;Molecular and Cellular Pharmacology;journal;19381247;0.366;Q2;21;0;10;0;11;8;0;0.00;United States;Lumitext Publishing;2009-ongoing;"Pharmaceutical Science (Q2); Molecular Biology (Q4)"
426;22769;Chemical and Pharmaceutical Bulletin;journal;00092363, 13475223;0.365;Q3;84;173;576;5914;816;567;1.48;34.18;Japan;Pharmaceutical Society of Japan;1958, 1962-ongoing;"Chemistry (miscellaneous) (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
427;15300154846;Journal of Occupational Medicine and Toxicology;journal;17456673;0.365;Q3;33;38;135;1681;336;133;2.56;44.24;United Kingdom;BioMed Central;2006-ongoing;"Public Health, Environmental and Occupational Health (Q3); Safety Research (Q3); Toxicology (Q3)"
428;29550;Journal of Biochemical and Molecular Toxicology;journal;10956670, 10990461;0.361;Q3;53;134;281;5576;718;272;2.93;41.61;United States;John Wiley & Sons Inc.;1998-ongoing;"Biochemistry (Q3); Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Toxicology (Q3); Molecular Biology (Q4); Molecular Medicine (Q4)"
429;24043;Journal of Labelled Compounds and Radiopharmaceuticals;journal;03624803, 10991344;0.359;Q3;41;106;244;4255;288;236;1.17;40.14;United States;John Wiley & Sons Inc.;1976-ongoing;"Analytical Chemistry (Q3); Biochemistry (Q3); Drug Discovery (Q3); Organic Chemistry (Q3); Radiology, Nuclear Medicine and Imaging (Q3); Spectroscopy (Q3)"
430;24605;Arhiv za Higijenu Rada i Toksikologiju;journal;18486312, 00041254;0.358;Q3;26;37;126;1706;191;116;1.49;46.11;Croatia;Institute for Medical Research and Occupational Health;1953-ongoing;"Public Health, Environmental and Occupational Health (Q3); Toxicology (Q3)"
431;19500157042;Currents in Pharmacy Teaching and Learning;journal;18771297;0.358;Q2;14;223;412;4911;309;384;0.67;22.02;Netherlands;Elsevier BV;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacy (Q2)"
432;25129;Journal of Environmental Pathology, Toxicology and Oncology;journal;07318898;0.356;Q3;43;28;88;1419;115;88;1.29;50.68;United States;Begell House;1984-1990, 1992-ongoing;"Health, Toxicology and Mutagenesis (Q3); Medicine (miscellaneous) (Q3); Pathology and Forensic Medicine (Q3); Toxicology (Q3)"
433;21100860941;Expert Review of Precision Medicine and Drug Development;journal;23808993;0.355;Q3;6;40;91;2783;107;75;1.43;69.58;United Kingdom;Taylor and Francis Ltd.;2016, 2018-ongoing;"Drug Discovery (Q3); Pharmacology (Q3); Genetics (Q4); Molecular Medicine (Q4)"
434;4600151527;Infectious Disorders - Drug Targets;journal;18715265;0.351;Q3;49;33;84;1174;83;74;0.96;35.58;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
435;16803;Antiviral Chemistry and Chemotherapy;journal;09563202;0.349;Q3;46;5;31;645;35;29;1.89;129.00;United Kingdom;SAGE Publications Inc.;2017-ongoing, 1991-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Virology (Q4)"
436;21100209502;Journal of Pharmacology and Pharmacotherapeutics;journal;0976500X, 09765018;0.349;Q3;26;37;160;961;170;115;1.61;25.97;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
437;19700175086;Drug, Healthcare and Patient Safety;journal;11791365;0.343;Q3;18;5;41;399;59;41;1.63;79.80;New Zealand;Dove Medical Press Ltd.;2009-ongoing;"Health Policy (Q3); Pharmacology (Q3)"
438;4700152612;Current Nanoscience;journal;15734137;0.336;Q2;37;65;287;2563;382;261;1.5;39.43;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Bioengineering (Q3); Biomedical Engineering (Q3); Biotechnology (Q3); Medicine (miscellaneous) (Q3); Nanoscience and Nanotechnology (Q3)"
439;130045;Journal of Applied Biomedicine;journal;12140287, 1214021X;0.335;Q2;26;51;109;2617;185;108;1.68;51.31;Spain;Elsevier Espana;2005-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Neuroscience (miscellaneous) (Q3)"
440;21100841779;ADMET and DMPK;journal;18487718;0.326;Q2;9;25;77;812;80;72;1.14;32.48;Croatia;International Association of Physical Chemists;2017-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Health (social science) (Q3); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
441;19700201137;Journal of Advanced Pharmaceutical Technology and Research;journal;01105558, 09762094;0.326;Q2;26;32;103;681;125;90;1.35;21.28;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
442;19383;Fluoride - Quarterly Reports;journal;00154725;0.323;Q4;41;34;119;1198;126;106;1.12;35.24;New Zealand;International Society for Flouride Research;1973-ongoing;"Agricultural and Biological Sciences (miscellaneous) (Q2); Chemistry (miscellaneous) (Q3); Dentistry (miscellaneous) (Q3); Health, Toxicology and Mutagenesis (Q3); Public Health, Environmental and Occupational Health (Q3); Biochemistry (Q4); Toxicology (Q4)"
443;19700201144;Journal of Pharmacy and Bioallied Sciences;journal;09764879, 09757406;0.323;Q2;27;28;474;906;505;456;1.04;32.36;India;Medknow Publications and Media Pvt. Ltd;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Bioengineering (Q3)"
444;18200156711;Bangladesh Journal of Pharmacology;journal;1991007X, 19910088;0.322;Q3;19;51;376;1506;266;345;0.8;29.53;Bangladesh;Bangladesh Pharmacological Society;2009-ongoing;Pharmacology (Q3)
445;4000148204;Pakistan Journal of Pharmaceutical Sciences;journal;1011601X;0.321;Q2;35;308;895;6125;699;895;0.69;19.89;Pakistan;University of Karachi;2005-ongoing;Pharmaceutical Science (Q2)
446;21100815317;Journal of Pharmacopuncture;journal;20936966, 22346856;0.318;Q3;7;32;72;1178;73;72;1.01;36.81;South Korea;Korean Pharmacopuncture Institute;2016-ongoing;"Complementary and Alternative Medicine (Q2); Pharmacology (Q3)"
447;21810;Farmacia;journal;00148237;0.316;Q2;19;150;448;4952;559;448;1.41;33.01;Romania;Uniunea Societatilor De Stiinte Medicale;1973-1987, 2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
448;19700201141;Journal of Ayurveda and Integrative Medicine;journal;09759476, 09762809;0.315;Q3;19;108;150;2516;159;123;1.41;23.30;Netherlands;Elsevier BV;2010-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3)"
449;19398;Acta Pharmaceutica;journal;13300075;0.314;Q2;49;40;124;1019;182;124;1.42;25.48;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1992-ongoing;"Pharmaceutical Science (Q2); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
450;11200153563;Drug Metabolism Letters;journal;18723128;0.312;Q2;23;21;74;619;62;65;0.96;29.48;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmaceutical Science (Q2); Biochemistry (medical) (Q3); Clinical Biochemistry (Q3); Pharmacology (medical) (Q3)"
451;4500151530;Personalized Medicine;journal;17410541;0.312;Q3;24;67;196;2263;162;166;1.05;33.78;United Kingdom;Future Medicine Ltd.;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
452;21100824046;Computational Toxicology;journal;24681113;0.311;Q4;5;29;21;1274;40;19;2.11;43.93;Netherlands;Elsevier BV;2017-ongoing;"Computer Science Applications (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
453;19700174889;Drug Target Insights;journal;11773928;0.31;Q2;10;2;16;48;30;15;2.1;24.00;New Zealand;Libertas Academica;2008-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3); Clinical Biochemistry (Q4)"
454;4400151415;Cardiovascular and Hematological Agents in Medicinal Chemistry;journal;18715257;0.307;Q3;36;24;62;1300;53;53;1.1;54.17;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
455;21100318814;Pharmaceutical patent analyst;journal;20468962;0.307;Q2;13;27;102;0;69;84;0.65;0.00;United Kingdom;Future Science;2012-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
456;22212;Scientia Pharmaceutica;journal;22180532, 00368709;0.306;Q2;34;46;144;1762;186;142;1.61;38.30;Austria;MDPI AG;1960-1961, 1973-ongoing;Pharmaceutical Science (Q2)
457;130016;Cutaneous and Ocular Toxicology;journal;15569527, 15569535;0.305;Q4;25;67;215;2071;190;211;0.99;30.91;United Kingdom;Taylor & Francis;1982-2000, 2005-ongoing;"Medicine (miscellaneous) (Q3); Toxicology (Q4)"
458;21717;Die Pharmazie;journal;00317144;0.305;Q2;56;140;381;3962;378;381;0.88;28.30;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-ongoing;Pharmaceutical Science (Q2)
459;25864;Heterocycles;journal;03855414;0.305;Q3;61;100;647;3584;549;640;0.87;35.84;Netherlands;Elsevier BV;1983, 1985-ongoing;"Analytical Chemistry (Q3); Organic Chemistry (Q3); Pharmacology (Q3)"
460;24640;Journal of Liquid Chromatography and Related Technologies;journal;1520572X, 10826076;0.305;Q2;46;131;469;4462;421;465;0.95;34.06;United States;Marcel Dekker Inc.;1996-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q3); Biochemistry (Q4); Clinical Biochemistry (Q4)"
461;21100285419;Expert Opinion on Orphan Drugs;journal;21678707;0.302;Q2;13;78;357;5954;246;339;0.77;76.33;United Kingdom;Taylor & Francis;2013-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Health Policy (Q3); Pharmacology (medical) (Q3)"
462;37697;Autonomic and Autacoid Pharmacology;journal;14748665;0.3;Q3;30;0;24;0;17;20;0.42;0.00;United Kingdom;Blackwell Publishing Inc.;2002-ongoing;Pharmacology (Q3)
463;19700175244;Current Radiopharmaceuticals;journal;18744710;0.299;Q3;21;32;82;1232;68;75;0.84;38.50;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmacology (Q3); Radiology, Nuclear Medicine and Imaging (Q3)"
464;19700201140;Systematic Reviews in Pharmacy;journal;09758453;0.296;Q2;11;16;29;749;43;29;1.6;46.81;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;Pharmaceutical Science (Q2)
465;4600151526;Cardiovascular and Hematological Disorders - Drug Targets;journal;1871529X;0.293;Q3;37;32;69;1399;72;61;1;43.72;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Hematology (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
466;23348;Journal of Environmental Biology;journal;23940379, 02548704;0.293;Q4;40;121;592;4008;386;590;0.6;33.12;India;Academy of Environmental Biology;1988-ongoing;"Environmental Engineering (Q3); Health, Toxicology and Mutagenesis (Q3); Toxicology (Q4)"
467;5800173402;Recent Patents on CNS Drug Discovery;journal;15748898;0.29;Q3;29;0;28;0;28;23;0.76;0.00;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Pharmacology (medical) (Q3); Psychiatry and Mental Health (Q3)"
468;21100853871;Current Metabolomics;journal;22132368, 2213235X;0.288;Q3;3;0;9;0;9;8;0.8;0.00;Netherlands;Bentham Science Publishers B.V.;2015-ongoing;"Analytical Chemistry (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Biochemistry (medical) (Q3); Drug Discovery (Q3); Organic Chemistry (Q4)"
469;19700201423;Journal of Pharmaceutical Health Services Research;journal;17598885, 17598893;0.287;Q2;12;61;109;1869;70;97;0.69;30.64;United Kingdom;John Wiley and Sons Ltd;2010-ongoing;"Economics, Econometrics and Finance (miscellaneous) (Q2); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)"
470;4600151507;Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry;journal;18715230;0.284;Q3;19;13;62;452;60;56;0.86;34.77;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
471;145580;International Journal of Peptide Research and Therapeutics;journal;15733149, 15733904;0.284;Q3;30;164;160;4918;170;157;1.08;29.99;Germany;Springer Verlag;1996-2002, 2005-ongoing;"Bioengineering (Q3); Drug Discovery (Q3); Analytical Chemistry (Q4); Biochemistry (Q4); Molecular Medicine (Q4)"
472;21100854647;Applied In Vitro Toxicology;journal;23321512, 23321539;0.283;Q4;2;36;7;1870;8;7;1.17;51.94;United States;Mary Ann Liebert Inc.;2015-ongoing;"Medical Laboratory Technology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
473;21100199816;Jundishapur Journal of Natural Pharmaceutical Products;journal;22287876, 17357780;0.28;Q2;15;47;147;1523;154;143;0.97;32.40;Netherlands;Kowsar Publishing Company;2011-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
474;21100389517;Drug Metabolism and Personalized Therapy;journal;23638907, 23638915;0.277;Q2;32;28;91;868;90;82;0.91;31.00;Germany;Walter de Gruyter GmbH;2015-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Pharmacology (medical) (Q3)"
475;29845;IARC Monographs on the Evaluation of Carcinogenic Risks to Humans;journal;10171606;0.276;Q4;38;29;26;4128;21;20;1.91;142.34;France;International Agency for Research on Cancer;1988-1997, 1999-2002, 2004, 2006-2008, 2010-ongoing;"Cancer Research (Q4); Toxicology (Q4)"
476;21100223537;European Journal of Hospital Pharmacy: Science and Practice;journal;20479956, 20479964;0.275;Q2;11;143;265;1698;143;202;0.68;11.87;Belgium;European Association of Hospital Pharmacists (EAHP);2012-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
477;22338;Hospital Pharmacy;journal;00185787;0.275;Q3;21;107;431;1675;239;381;0.55;15.65;United States;Thomas Land Publishers Inc.;1973-ongoing;"Pharmacy (Q2); Pharmacology (Q3); Pharmacology (medical) (Q3)"
478;17700155034;Natural product communications;journal;15559475, 1934578X;0.275;Q3;35;387;1457;11228;1038;1413;0.58;29.01;United States;Natural Product Communications;2008-ongoing;"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Plant Science (Q3)"
479;19700177407;Interdisciplinary Toxicology;journal;13379569, 13376853;0.274;Q3;23;14;67;645;120;66;1.24;46.07;Slovakia;Slovak Toxicology Society SETOX;2010-ongoing;"Pharmacology (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
480;79053;Natural Product Sciences;journal;12263907;0.268;Q3;22;34;150;812;124;149;0.94;23.88;South Korea;Korean Society of Pharmacognosy;1997-ongoing;"Drug Discovery (Q3); Organic Chemistry (Q4)"
481;19700175099;Topics in Medicinal Chemistry;book series;18622461;0.266;Q3;8;45;63;5584;32;44;0.84;124.09;Germany;Springer Verlag;2009-ongoing;"Drug Discovery (Q3); Molecular Medicine (Q4)"
482;4700152609;Current Computer-Aided Drug Design;journal;15734099;0.265;Q3;24;39;114;1534;98;96;1.14;39.33;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Drug Discovery (Q3); Medicine (miscellaneous) (Q3); Molecular Medicine (Q4)"
483;21811;Farmacia Hospitalaria;journal;11306343;0.264;Q3;21;58;221;983;136;169;0.73;16.95;Spain;Aran Ediciones SA;1990-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology (Q3)"
484;21100463829;Chinese Journal of Population Resources and Environment;journal;23254262, 10042857;0.261;Q4;9;38;129;1429;106;120;1.14;37.61;United Kingdom;Taylor and Francis Ltd.;2015-ongoing;"Demography (Q2); Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
485;21100398550;Orphan Drugs: Research and Reviews;journal;22306161;0.259;Q2;2;0;14;0;7;14;0.25;0.00;New Zealand;Dove Medical Press Ltd.;2017-ongoing, 2014-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3)"
486;22392;Indian Journal of Pharmaceutical Sciences;journal;0250474X, 19983743;0.256;Q2;50;131;340;4764;294;337;0.63;36.37;India;Medknow Publications;1978-ongoing;Pharmaceutical Science (Q2)
487;19700175096;Pharmacognosy Journal;journal;09753575;0.254;Q3;14;234;291;6690;238;291;0.82;28.59;India;Pharmacognosy Network Worldwide;2009-ongoing;"Drug Discovery (Q3); Pharmacology (Q3)"
488;19700189400;Pharmaceutical Sciences;journal;23832886, 1735403X;0.252;Q2;12;48;135;1661;179;128;1.24;34.60;Iran;Tabriz University of Medical Sciences;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
489;19400157518;Rasayan Journal of Chemistry;journal;09760083, 09741496;0.252;Q2;18;217;389;5372;424;389;1.22;24.76;India;Rasayan Journal;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Chemical Engineering (miscellaneous) (Q3); Chemistry (miscellaneous) (Q3); Energy (miscellaneous) (Q3); Biochemistry (Q4)"
490;21100226424;Toxicology and Environmental Health Sciences;journal;20059752;0.252;Q4;12;39;121;1573;85;120;0.76;40.33;South Korea;Korean Society of Environmental Risk Assessment and Health Science;2009-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
491;4700152608;African Journal of Traditional, Complementary and Alternative Medicines;journal;01896016;0.249;Q3;36;0;427;0;338;425;0.85;0.00;Nigeria;African Networks on Ethnomedicines;1970, 1973-1978, 1981-1982, 1991, 1995, 2002, 2006-2016 (cancelled);"Complementary and Alternative Medicine (Q2); Drug Discovery (Q3); Medicine (miscellaneous) (Q3)"
492;21100304895;Archives of Clinical Infectious Diseases;journal;23452641;0.249;Q4;10;81;138;2437;100;126;0.78;30.09;Iran;Shahid Beheshti University of Medical Sciences;2012-ongoing;"Cardiology and Cardiovascular Medicine (Q3); Critical Care and Intensive Care Medicine (Q3); Infectious Diseases (Q3); Public Health, Environmental and Occupational Health (Q3); Toxicology (Q4)"
493;4100151708;Inflammation and Allergy - Drug Targets;journal;18715281;0.248;Q3;42;0;25;0;28;20;0;0.00;United Arab Emirates;Bentham Science Publishers;2006-2015;"Medicine (miscellaneous) (Q3); Pharmacology (Q3); Immunology (Q4); Immunology and Allergy (Q4)"
494;21100854830;Clinical Phytoscience;journal;21991197;0.244;Q3;2;0;4;0;8;4;2.5;0.00;Switzerland;Springer International Publishing AG;2015, 2017-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Plant Science (Q3)"
495;21100195303;Eurasian Journal of Analytical Chemistry;journal;13063057;0.242;Q2;8;129;177;3266;152;177;0.87;25.32;Turkey;Moment Publications;2011-ongoing;"Pharmaceutical Science (Q2); Analytical Chemistry (Q4); Electrochemistry (Q4); Spectroscopy (Q4)"
496;21100785532;International Journal of Pharma Medicine and Biological Sciences;journal;22785221;0.242;Q2;1;0;3;0;1;3;0.33;0.00;India;International Journal of Pharma Medicine and Biological Sciences;2012, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3)"
497;3900148201;International Journal of Pharmacology;journal;18125700, 18117775;0.239;Q3;29;139;330;4880;278;329;0.8;35.11;Pakistan;Asian Network for Scientific Information;2006-ongoing;Pharmacology (Q3)
498;29953;Journal of Experimental Therapeutics and Oncology;journal;13594117;0.239;Q3;36;41;77;922;54;77;0.58;22.49;United States;Old City Publishing Inc.;1996, 2002-ongoing;"Drug Discovery (Q3); Pharmacology (Q3); Cancer Research (Q4)"
499;19700175004;Open Medicinal Chemistry Journal;journal;18741045;0.237;Q2;15;13;22;455;23;22;1.21;35.00;United Arab Emirates;Bentham Science Publishers;2009-ongoing;"Pharmaceutical Science (Q2); Drug Discovery (Q3); Pharmacology (Q3); Molecular Medicine (Q4)"
500;19700174810;International Journal of Pharmacy and Pharmaceutical Sciences;journal;09751491;0.232;Q2;37;0;1836;0;1815;1820;1.02;0.00;India;International Journal of Pharmacy and Pharmaceutical Sciences;2009-2016 (cancelled);"Pharmaceutical Science (Q2); Pharmacology (Q3)"
501;110097;Food and Drug Law Journal;journal;1064590X;0.231;Q3;18;19;74;2066;37;71;0.43;108.74;United States;Food and Drug Law Institute;1992-ongoing;"Law (Q3); Medicine (miscellaneous) (Q3); Pharmacology (Q3); Public Health, Environmental and Occupational Health (Q4)"
502;19700189100;Pharmaceutical Medicine;journal;11782595, 14735679;0.23;Q3;15;31;88;1194;69;83;0.81;38.52;United Kingdom;Adis International Ltd.;2008-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
503;21100789875;Proceedings of the 3rd ACM Conference on Systems for Energy-Efficient Built Environments, BuildSys 2016;conference and proceedings;00002016;0.23;-;7;0;51;0;99;49;2.02;0.00;United States;;2016;"Health, Toxicology and Mutagenesis; Toxicology"
504;21100833039;Journal of HerbMed Pharmacology;journal;23455004;0.229;Q3;8;34;96;1205;85;95;0.78;35.44;Iran;Nickan Research Institute;2015-ongoing;Drug Discovery (Q3)
505;19461;Annales Pharmaceutiques Francaises;journal;00034509;0.225;Q2;22;55;151;1546;109;144;0.75;28.11;France;Elsevier Masson;1946-ongoing;"Pharmaceutical Science (Q2); Pharmacology (Q3)"
506;19700177128;Journal of Young Pharmacists;journal;09751505, 09751483;0.225;Q2;22;141;299;3085;194;286;0.68;21.88;India;EManuscript Services;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
507;21100236605;Journal of Applied Pharmaceutical Science;journal;22313354;0.224;Q2;28;276;1073;9517;759;1064;0.62;34.48;India;MediPoeia;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2); Medicine (miscellaneous) (Q3); Pharmacology (medical) (Q3)"
508;17700155411;Research Journal of Environmental Toxicology;journal;18193420;0.224;Q4;12;0;55;0;43;55;0.56;0.00;United States;Academic Journals Inc.;2009-2016 (cancelled);"Pollution (Q3); Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
509;4700152426;Current Pharmaceutical Analysis;journal;15734129;0.218;Q2;22;82;179;2329;114;170;0.68;28.40;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Pharmaceutical Science (Q2); Biochemistry (Q4); Biophysics (Q4); Molecular Medicine (Q4)"
510;19900192174;International Journal of Applied Pharmaceutics;journal;09757058;0.216;Q3;9;164;198;5267;199;198;0.96;32.12;India;International Journal of Applied Pharmaceutics;2011-ongoing;Pharmaceutical Science (Q3)
511;21100854014;Future Journal of Pharmaceutical Sciences;journal;23147245;0.213;Q3;1;0;1;0;1;1;0;0.00;Egypt;Future University;2015;Pharmaceutical Science (Q3)
512;20500195212;International Journal of Drug Delivery Technology;journal;09754415;0.213;Q3;7;22;79;435;17;79;0.2;19.77;Australia;International Journal of Drug Delivery Technology;2011-ongoing;Pharmaceutical Science (Q3)
513;19430;Adverse Drug Reaction Bulletin;journal;00446394;0.212;Q3;7;4;20;187;7;18;0.55;46.75;United States;Lippincott Williams & Wilkins Ltd.;1970, 1973-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
514;21100853564;AAPS Advances in the Pharmaceutical Sciences Series;book series;22107371, 2210738X;0.21;Q3;6;0;49;0;28;21;1.46;0.00;Germany;Springer Verlag;2014-ongoing;Pharmaceutical Science (Q3)
515;19405;Acta Poloniae Pharmaceutica;journal;00016837;0.209;Q3;35;148;544;4754;295;534;0.46;32.12;Poland;Polskie Towarzystwo Farmaceutyczne/Polish Pharmaceutical Society;1951-1955, 1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q3)"
516;18800156720;Dissolution Technologies;journal;1521298X;0.207;Q3;28;22;83;579;47;68;0.73;26.32;United States;Dissolution Technologies, Inc.;2008-ongoing;Pharmaceutical Science (Q3)
517;144963;Drug Discovery Today: Disease Models;journal;17406757;0.207;Q4;23;0;80;0;40;70;0.24;0.00;Netherlands;Elsevier BV;2004-ongoing;"Drug Discovery (Q4); Molecular Medicine (Q4)"
518;130038;Letters in Drug Design and Discovery;journal;15701808;0.207;Q3;28;162;385;5833;330;381;0.93;36.01;United Arab Emirates;Bentham Science Publishers;2005-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Molecular Medicine (Q4)"
519;19200156945;Boletin Latinoamericano y del Caribe de Plantas Medicinales y Aromaticas;journal;07177917;0.204;Q3;16;35;124;2373;79;124;0.52;67.80;Chile;Universidad de Santiago de Chile;2008-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q3); Drug Discovery (Q4); Plant Science (Q4)"
520;19700175758;International Journal of Drug Development and Research;journal;09759344;0.204;Q2;17;0;21;0;17;21;0;0.00;India;International Journal of Drug Development and Research;2010-2015 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
521;21758;Prescrire International;journal;11677422;0.204;Q3;11;71;408;840;52;345;0.18;11.83;France;Association Mieux Prescrire;1996-ongoing;"Pharmacology (Q3); Pharmacology (medical) (Q3)"
522;19700174632;Journal of Receptor, Ligand and Channel Research;journal;1178699X;0.203;Q3;7;1;6;98;4;6;1;98.00;United Kingdom;Dove Medical Press Ltd;2010-ongoing;"Pharmacology (Q3); Biochemistry (Q4); Biophysics (Q4); Cell Biology (Q4)"
523;11500153306;Recent Patents on Drug Delivery and Formulation;journal;18722113;0.203;Q3;25;17;74;764;51;70;0.61;44.94;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Biomedical Engineering (Q4)"
524;19700175858;Journal of Pharmacognosy and Phytotherapy;journal;21412502;0.202;Q4;18;0;41;0;287;41;6.47;0.00;Nigeria;Academic Journals;2010-2016 (cancelled);Drug Discovery (Q4)
525;35190;Revista Espanola de Quimioterapia;journal;02143429;0.202;Q4;23;106;276;2536;143;230;0.66;23.92;Spain;Sociedad Española de Quimioterapia;1989-ongoing;"Medicine (miscellaneous) (Q3); Microbiology (medical) (Q4); Pharmacology (Q4)"
526;21100216519;Journal of Pharmaceutical Negative Results;journal;09769234, 22297723;0.201;Q3;5;12;35;283;12;28;0.55;23.58;India;Medknow Publications and Media Pvt. Ltd;2010-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
527;19700182901;Brazilian Journal of Pharmaceutical Sciences;journal;19848250, 21759790;0.2;Q2;32;103;288;3942;198;283;0.55;38.27;Brazil;Universidade de Sao Paulo;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q2)
528;16698;Revista Brasileira de Plantas Medicinais;journal;15160572;0.2;Q4;23;0;222;0;134;215;0.82;0.00;Brazil;Fundacao do Instituto de Biociencias;1999-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
529;19700174978;American Journal of Pharmacy Benefits;journal;19454481;0.198;Q3;11;6;114;121;30;90;0.38;20.17;United States;Managed Care & Healthcare Communications LLC;2010-ongoing;"Business and International Management (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Decision Sciences (miscellaneous) (Q4)"
530;18800156708;Tropical Journal of Pharmaceutical Research;journal;15965996;0.197;Q3;29;335;1051;8017;572;1042;0.48;23.93;Nigeria;University of Benin;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
531;21100256959;Biomarkers and Genomic Medicine;journal;22140247;0.195;Q4;7;0;23;0;20;23;0;0.00;United States;Elsevier BV;2013-2015;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q3); Medicine (miscellaneous) (Q3); Biomedical Engineering (Q4); Drug Discovery (Q4)"
532;21100197160;Research Journal of Pharmacy and Technology;journal;09743618, 0974360X;0.194;Q3;14;347;1296;8117;491;1294;0.41;23.39;India;A and V Publication;2011-ongoing;"Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
533;21100853873;International Journal of Current Pharmaceutical Research;journal;09757066;0.192;Q3;3;0;10;0;11;10;1.5;0.00;India;Innovare Academic Sciences Pvt Ltd.;2014-ongoing;Pharmaceutical Science (Q3)
534;19700181241;Physiology and Pharmacology;journal;24765236, 24765244;0.192;Q4;9;32;117;1329;63;115;0.56;41.53;Iran;Neuroscience Research Center;2009-ongoing;"Pharmacology (Q4); Physiology (Q4)"
535;5800173401;Current Bioactive Compounds;journal;15734072;0.191;Q3;21;55;123;1960;76;110;0.69;35.64;United Arab Emirates;Bentham Science Publishers;2007-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
536;21100818733;Archives of Pharmacy Practice;journal;2045080X;0.189;Q3;2;0;5;0;1;5;0.2;0.00;India;Medknow Publications and Media Pvt. Ltd;2016-ongoing;Pharmaceutical Science (Q3)
537;110172;Progress in Drug Research;book series;0071786X;0.189;Q3;38;10;65;1125;14;7;0;112.50;Switzerland;Birkhauser Verlag;1959-1966, 1968-1969, 1972-2003, 2005, 2007-2008, 2011, 2014-ongoing;"Medicine (miscellaneous) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
538;58808;Pharmaceutical Care and Research;journal;16712838;0.188;Q3;7;130;405;1480;31;401;0.07;11.38;China;Yao xue fu wu yu yan jiu za zhi she;2004-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
539;21715;Pharmazeutische Industrie;journal;16167074, 0031711X;0.188;Q3;17;250;818;1772;48;772;0.08;7.09;Germany;Editio Cantor Verlag;1960-1961, 1973-ongoing;Pharmaceutical Science (Q3)
540;19408;Actualites Pharmaceutiques;journal;05153700;0.187;Q4;5;171;526;1385;24;419;0.06;8.10;Netherlands;Elsevier BV;1961, 1963, 1996-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
541;21100440523;Interaction Design and Architecture(s);journal;18269745, 22832998;0.185;Q4;8;7;122;246;103;108;0.64;35.14;Italy;Scuola IaD;2015-ongoing;"Architecture (Q2); Media Technology (Q2); Social Sciences (miscellaneous) (Q3); Computer Science Applications (Q4); Human-Computer Interaction (Q4); Pharmacology (Q4)"
542;25425;Journal of Herbs, Spices and Medicinal Plants;journal;15403580, 10496475;0.184;Q4;24;34;99;1062;58;97;0.63;31.24;United States;The Haworth Herbal Press;1992-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
543;21100201517;RSC Drug Discovery Series;book series;20413203;0.181;Q4;7;76;277;6428;88;133;2.05;84.58;United Kingdom;Royal Society of Chemistry;2010, 2014-ongoing;Drug Discovery (Q4)
544;21100854233;Advances in Delivery Science and Technology;book series;21926204;0.178;Q3;2;1;4;401;1;4;0;401.00;Germany;Springer Verlag;2015;Pharmaceutical Science (Q3)
545;21100456601;Journal of Pharmacy and Pharmacognosy Research;journal;07194250;0.177;Q3;5;46;83;1459;38;80;0.49;31.72;Chile;Asociacion Academica de Ciencias Farmaceuticas de Antofagasta (ASOCIFA);2013-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
546;19700200708;Journal of Global Pharma Technology;journal;09758542;0.176;Q3;10;378;299;9122;120;299;0.4;24.13;India;Journal of Global Pharma Technology;2010-ongoing;Pharmaceutical Science (Q3)
547;23107;Journal of Pharmacy Technology;journal;87551225;0.175;Q3;9;37;112;1163;40;112;0.36;31.43;United States;SAGE Publications Inc.;1989-ongoing;Pharmaceutical Science (Q3)
548;20065;BioPharm International;journal;1542166X;0.173;Q3;25;113;408;488;111;198;0.59;4.32;United States;UBM Medica Periodical Publication;2002-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4)"
549;15500154707;International Journal of Biological Chemistry;journal;1819155X;0.173;Q4;12;0;30;0;24;30;3;0.00;Pakistan;ANSInet;2009-2016 (cancelled);"Biochemistry (Q4); Pharmacology (Q4)"
550;21211;Pharmacy Education;journal;14772701, 15602214;0.172;Q3;15;32;110;811;49;110;0.3;25.34;United Kingdom;Taylor & Francis;1973-1978, 2002-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3); Education (Q4)"
551;21086;Pharmaceutical Chemistry Journal;journal;15739031, 0091150X;0.171;Q4;26;218;569;4318;210;524;0.4;19.81;United States;Kluwer Academic/Plenum Publishers;1967-1977, 1979-1994, 1996-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
552;19200156909;Indian Journal of Pharmaceutical Education and Research;journal;00195464;0.169;Q3;17;108;356;3106;166;353;0.47;28.76;India;Association of Pharmaceutical Teachers of India;2008-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
553;21100451405;Natural Products Journal;journal;22103163, 22103155;0.169;Q4;9;31;112;1910;46;102;0.4;61.61;Netherlands;Bentham Science Publishers B.V.;2011-ongoing;"Complementary and Alternative Medicine (Q3); Drug Discovery (Q4)"
554;11900154394;Oriental Journal of Chemistry;journal;0970020X, 22315039;0.168;Q4;18;336;1109;9325;737;1109;0.68;27.75;India;Scientific Publishers;2008-ongoing;"Biochemistry (Q4); Chemistry (miscellaneous) (Q4); Drug Discovery (Q4); Environmental Chemistry (Q4)"
555;19700174904;Asian Journal of Pharmaceutical and Clinical Research;journal;09742441, 24553891;0.167;Q3;26;1305;2401;39730;1236;2393;0.48;30.44;India;Asian Journal of Pharmaceutical and Clinical Research;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacology (Q4)"
556;21100201958;Journal of Chinese Pharmaceutical Sciences;journal;10031057;0.167;Q3;10;91;308;2189;94;304;0.32;24.05;China;Editorial Office of Journal of Chinese Pharmaceutical Sciences;2011-ongoing;Pharmaceutical Science (Q3)
557;19700174931;Asian Journal of Pharmaceutics;journal;1998409X, 09738398;0.166;Q3;16;277;307;7692;152;307;0.47;27.77;India;Medknow Publications;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
558;22881;Yao xue xue bao = Acta pharmaceutica Sinica;journal;05134870;0.166;Q3;29;215;789;7543;344;789;0.43;35.08;China;Nongton Jie;1960, 1962-1966, 1979-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Molecular Medicine (Q4)"
559;22908;Chinese Pharmacological Bulletin;journal;10011978;0.165;Q4;15;342;1038;5554;507;1037;0.53;16.24;China;Publication Centre of Anhui Medical University;1993-ongoing;Pharmacology (Q4)
560;23440;Indian Journal of Physiology and Pharmacology;journal;00195499;0.165;Q4;45;63;176;1736;55;158;0.2;27.56;India;All India Institute of Medical Sciences;1959-ongoing;"Pharmacology (Q4); Physiology (Q4); Physiology (medical) (Q4)"
561;21100854827;Journal of Nanopharmaceutics and Drug Delivery;journal;21679312, 21679320;0.165;Q3;1;0;2;0;2;2;1;0.00;United States;American Scientific Publishers;2016-ongoing;"Medicine (miscellaneous) (Q3); Pharmaceutical Science (Q3); Biomedical Engineering (Q4)"
562;5800179590;Pharmacologyonline;journal;18278620;0.165;Q4;21;100;201;3262;71;200;0.31;32.62;Italy;SILAE;2007-ongoing;"Drug Discovery (Q4); Pharmacology (Q4)"
563;144879;Toxicology International;journal;09716580;0.165;Q4;21;0;160;0;58;157;0.13;0.00;India;Society of Toxicology;2005-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
564;21100788832;International Journal of Medicinal Chemistry;journal;20902069, 20902077;0.164;Q4;3;0;4;0;2;4;0.67;0.00;United States;Hindawi Publishing Corporation;2014-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
565;21100376682;Toxicologie Analytique et Clinique;journal;23520078;0.164;Q4;5;34;136;895;48;117;0.46;26.32;Italy;Elsevier Masson SAS;2014-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
566;21100812583;ACM International Conference Proceeding Series;conference and proceedings;00002016;0.163;-;1;0;13;0;8;11;0.73;0.00;United States;;2016;"Organic Chemistry; Pharmaceutical Science"
567;4700151603;Journal of Pharmacy of Istanbul University;journal;03677524;0.163;Q3;7;0;29;0;18;28;0.42;0.00;Turkey;Istanbul Universitesi Eczacilik Fakultesi;2005, 2007-2008, 2010, 2012, 2015-ongoing;"Pharmaceutical Science (Q3); Pharmacy (Q3)"
568;19700174893;Dhaka University Journal of Pharmaceutical Sciences;journal;18161839, 18161820;0.162;Q3;10;33;96;831;26;93;0.23;25.18;Bangladesh;University of Dhaka;2007-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3)"
569;22937;Zhongguo Zhongyao Zazhi;journal;10015302;0.162;Q3;26;707;2126;12807;741;2126;0.28;18.11;China;Zhongguo Zhongyi Yanjiuyuan;1989-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (medical) (Q3); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)"
570;19700174933;Journal of Pharmaceutical Sciences and Research;journal;09751459;0.161;Q3;20;771;1080;17890;479;1065;0.41;23.20;India;PharmaInfo Publications;2009-ongoing;Pharmaceutical Science (Q3)
571;21292;Epitheorese Klinikes Farmakologias kai Farmakokinetikes;journal;10116575;0.16;Q4;4;17;61;571;11;57;0.08;33.59;Bulgaria;Pharmakon Press;1989-ongoing;"Pharmacology (medical) (Q3); Pharmacology (Q4)"
572;19700180785;Studies in Natural Products Chemistry;book series;15725995;0.16;Q4;33;70;148;9978;110;13;6.92;142.54;Netherlands;Elsevier BV;1995-1997, 2000-2003, 2005-2006, 2008, 2012-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4)"
573;70864;Anales de la Real Academia Nacional de Farmacia;journal;1697428X, 16974271;0.159;Q3;8;22;136;1309;16;118;0.13;59.50;Spain;Real Academia Nacional de Farmacia;2004-2005;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Cell Biology (Q4); Molecular Biology (Q4)"
574;15600154705;EnvironmentAsia;journal;19061714;0.159;Q4;14;33;91;1027;46;91;0.52;31.12;Thailand;Thai Society of Higher Education Institutes on Environment;2009-ongoing;"Environmental Science (miscellaneous) (Q3); Toxicology (Q4)"
575;23171;Korean Journal of Pharmacognosy;journal;02533073;0.159;Q3;14;45;151;1338;34;151;0.19;29.73;South Korea;Korean Society of Pharmacognosy;1990-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (Q4)"
576;21823;Farmatsija;journal;04280296;0.158;Q3;5;17;67;442;14;67;0.23;26.00;Bulgaria;Meditsinski Universitet - Sofia;1945, 1954-1955, 1987-1991, 1997-ongoing;"Pharmaceutical Science (Q3); Pharmacology (medical) (Q3); Pharmacy (Q3)"
577;22934;Chinese Pharmaceutical Journal;journal;10012494;0.157;Q3;19;105;1210;2107;150;1210;0.13;20.07;China;Zhonogguo Yaoxuehui;1993-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
578;24111;Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry;journal;03764699;0.157;Q3;43;0;196;0;85;195;0.42;0.00;India;Scientific Publishers;1970, 1973-1978, 1981, 1989-1991, 1996-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Organic Chemistry (Q4)"
579;22858;Japanese Pharmacology and Therapeutics;journal;03863603;0.157;Q4;13;150;369;2571;74;366;0.19;17.14;Japan;Life Science Publishing Co. Ltd.;1981-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
580;80593;Journal of Medicinal Plants;journal;16840240;0.156;Q4;16;72;175;2815;62;173;0.29;39.10;Iran;Pizhuhishkadh-i giyahan-i darayiva faravardah ha-vi tabbii;2004-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
581;21100399725;Journal of Reports in Pharmaceutical Sciences;journal;23225106, 23221232;0.156;Q3;5;23;54;783;31;54;0.54;34.04;Iran;Kermanshah University of Medical Sciences;2012-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biomedical Engineering (Q4); Pharmacology (medical) (Q4)"
582;19800188074;Medicinal Plants - International Journal of Phytomedicines and Related Industries;journal;09754261, 09756892;0.156;Q4;8;53;136;1606;27;133;0.18;30.30;Netherlands;IOS Press;2010-ongoing;"Drug Discovery (Q4); Organic Chemistry (Q4); Plant Science (Q4)"
583;19700174971;Indian Journal of Forensic Medicine and Toxicology;journal;09739122, 09739130;0.155;Q4;18;258;392;4178;27;391;0.08;16.19;India;Aall India Institute of Medical Sciences;2008-ongoing;"Law (Q3); Health, Toxicology and Mutagenesis (Q4); Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
584;19700183012;Iranian Journal of Pharmaceutical Sciences;journal;17352444;0.155;Q3;9;20;48;501;28;48;0.58;25.05;Iran;Shiraz University of Medical Sciences;2010-ongoing;"Pharmaceutical Science (Q3); Bioengineering (Q4)"
585;21100874234;Latin American Journal of Pharmacy;journal;23623853, 03262383;0.155;Q3;17;372;1025;8645;347;1025;0.37;23.24;Argentina;Colegio de Farmaceuticos de la Provincia de Buenos Aires;2007-ongoing;"Pharmaceutical Science (Q3); Drug Discovery (Q4)"
586;21100239829;Current Issues in Pharmacy and Medical Sciences;journal;2084980X, 23006676;0.154;Q4;7;40;139;1087;47;139;0.37;27.18;Poland;Uniwersytet Medyczny w Lublinie;2012-ongoing;"Biochemistry (Q4); Medicine (miscellaneous) (Q4); Molecular Biology (Q4); Pharmacology (Q4)"
587;17700156303;Neuromethods;book series;19406045, 08932336;0.154;Q3;17;209;684;13879;193;278;3;66.41;United States;Humana Press, Inc.;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Neuroscience (miscellaneous) (Q4); Psychiatry and Mental Health (Q4)"
588;19700200880;Botulinum Journal;journal;17547326;0.153;Q3;5;0;6;0;2;6;0.33;0.00;Switzerland;Inderscience Publishers;2009-2013, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry (Q4); Cellular and Molecular Neuroscience (Q4)"
589;4700152607;Current Enzyme Inhibition;journal;15734080;0.153;Q4;15;20;61;698;25;54;0.35;34.90;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Biochemistry (Q4); Drug Discovery (Q4); Molecular Medicine (Q4)"
590;145096;Neuropsychopharmacologia Hungarica : a Magyar Pszichofarmakologiai Egyesulet lapja = official journal of the Hungarian Association of Psychopharmacology;journal;14198711;0.153;Q3;14;19;71;485;19;63;0.29;25.53;Hungary;Neuroline;2004-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Neurology (clinical) (Q4); Neuropsychology and Physiological Psychology (Q4); Neuroscience (miscellaneous) (Q4)"
591;19700175056;Jordan Journal of Pharmaceutical Sciences;journal;19957157;0.152;Q3;8;12;38;310;13;38;0.35;25.83;Jordan;University of Jordan;2009-ongoing;Pharmaceutical Science (Q3)
592;73430;Pharmaceutical Technology;journal;15432521;0.152;Q3;35;219;588;965;77;202;0.83;4.41;United States;UBM Medica Periodical Publication;1979-1985, 1987, 1996-ongoing;"Pharmaceutical Science (Q3); Biophysics (Q4)"
593;19700174658;Regulatory Rapporteur;trade journal;17428955;0.152;Q3;5;72;193;446;20;138;0.15;6.19;United Kingdom;The Organisation for Professionals in Regulatory Affairs;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacy (Q3)"
594;6400153143;Turkish Journal of Pharmaceutical Sciences;journal;1304530X;0.152;Q3;11;54;119;1620;56;119;0.44;30.00;Turkey;Turkish Pharmacists Association;2006-ongoing;"Pharmaceutical Science (Q3); Molecular Medicine (Q4)"
595;21100782803;Current Psychopharmacology;journal;22115560, 22115579;0.15;Q4;3;0;20;0;9;19;0.56;0.00;Netherlands;Bentham Science Publishers B.V.;2012, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
596;20572;PZ Prisma;journal;09455566;0.149;Q3;5;35;97;782;8;83;0.14;22.34;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1994-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
597;22854;Yakugaku Zasshi;journal;00316903;0.148;Q3;37;209;614;4073;149;514;0.33;19.49;Japan;Pharmaceutical Society of Japan;1961-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
598;19446;American Pharmaceutical Review;journal;10998012;0.147;Q3;20;84;287;888;55;254;0.2;10.57;United States;Russell Publishing LLC;2002-ongoing;Pharmaceutical Science (Q3)
599;73076;Drug Discovery World;journal;14694344;0.147;Q4;10;17;90;206;10;81;0.11;12.12;United Kingdom;R J Communications & Media World Ltd.;2004-ongoing;Drug Discovery (Q4)
600;21100853529;International Journal of Pharmaceutical and Phytopharmacological Research;journal;22496084, 22501029;0.146;Q3;1;0;3;0;1;3;0;0.00;India;International Journal of Pharmaceutical and Phytopharmacological Research;2014-2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)"
601;20564;Ceska a Slovenska Farmacie;journal;12107816, 18054439;0.145;Q3;15;22;83;1133;40;83;0.36;51.50;Czech Republic;Nakladatelske Stredisko CLSJE Purkyne;1994-ongoing;Pharmaceutical Science (Q3)
602;21100301409;Issues in Toxicology;book series;17577179;0.145;Q4;12;46;150;4530;47;36;0;98.48;United Kingdom;Royal Society of Chemistry;2007-ongoing;"Health, Toxicology and Mutagenesis (Q4); Pharmacology (Q4); Toxicology (Q4)"
603;21100218041;Anti-Infective Agents;journal;22113533, 22113525;0.144;Q4;21;20;59;906;38;52;0.62;45.30;United Arab Emirates;Bentham Science Publishers;2012-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4)"
604;21100228007;Archives of Razi Institute;journal;03653439;0.144;Q4;5;35;97;958;27;97;0.19;27.37;Iran;Razi Vaccine and Serum Research Institute;2012-ongoing;"Immunology and Microbiology (miscellaneous)  (Q4); Toxicology (Q4); Veterinary (miscellaneous) (Q4)"
605;19700174961;BioProcess International;trade journal;15426319;0.143;Q4;20;0;254;0;67;253;0.22;0.00;United States;BioProcess International;2009-ongoing;"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Drug Discovery (Q4)"
606;19700174900;International Journal of Green Pharmacy;journal;19984103, 09738258;0.143;Q3;18;206;312;5979;110;312;0.32;29.02;India;Medknow Publications;2009-ongoing;"Pharmaceutical Science (Q3); Pharmacology (Q4)"
607;21100795043;Journal of Natural Remedies;journal;23203358, 09725547;0.143;Q4;16;14;51;497;21;51;0.5;35.50;India;Natural Remedies Pvt Ltd.;2002-ongoing;Pharmacology (Q4)
608;19700175785;Open Access Journal of Clinical Trials;journal;11791519;0.143;Q3;9;3;19;128;12;19;0.38;42.67;New Zealand;Dove Medical Press Ltd;2009-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
609;19700174924;Biomedical and Pharmacology Journal;journal;09746242, 24562610;0.142;Q4;12;255;816;7430;295;815;0.46;29.14;India;Oriental Scientific Pub. Co.;2009-ongoing;Pharmacology (Q4)
610;19700200860;International Journal of Current Pharmaceutical Review and Research;journal;0976822X;0.142;Q3;9;0;160;0;72;160;0.56;0.00;India;Publishers, In-IJCPR;2010-2016 (cancelled);Pharmaceutical Science (Q3)
611;19700188319;International Journal of Pharmaceutical Sciences Review and Research;journal;0976044X;0.14;Q3;24;0;1227;0;344;1227;0.22;0.00;India;Global Research Online;2010-2016 (cancelled);Pharmaceutical Science (Q3)
612;21100242405;Marmara Pharmaceutical Journal;journal;13090801;0.14;Q3;10;67;184;2507;67;184;0.31;37.42;Turkey;Marmara University;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
613;5100152606;Biosciences Biotechnology Research Asia;journal;09731245, 24562602;0.139;Q4;13;0;740;0;267;740;0.34;0.00;India;Oriental Scientific Pub. Co.;2005-2016 (cancelled);"Agronomy and Crop Science (Q4); Biotechnology (Q4); Drug Discovery (Q4)"
614;17300154738;Current Trends in Biotechnology and Pharmacy;journal;09738916;0.139;Q3;10;22;99;640;32;99;0.32;29.09;India;Association of Biotechnology and Pharmacy;2009-ongoing;"Pharmaceutical Science (Q3); Biotechnology (Q4); Drug Discovery (Q4)"
615;5800173394;Current Drug Therapy;journal;15748855;0.138;Q3;14;14;56;678;20;51;0.56;48.43;United Arab Emirates;Bentham Science Publishers;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
616;21100237602;Journal of Pharmacy and Nutrition Sciences;journal;19275951, 22233806;0.138;Q3;8;21;66;629;19;65;0.38;29.95;Canada;Lifescience Global;2011-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health (social science) (Q4); Medicine (miscellaneous) (Q4); Nutrition and Dietetics (Q4)"
617;9100153105;Current Topics in Pharmacology;journal;09724559;0.137;Q4;4;11;25;994;8;25;0.2;90.36;India;Research Trends;2006-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
618;19700174992;European Journal of Oncology Pharmacy;journal;20327072, 17833914;0.137;Q4;3;1;30;34;3;5;0.25;34.00;Belgium;Pharma Publishing and Media Europe;2008-ongoing;"Oncology (Q4); Pharmacology (Q4)"
619;19700174609;Clinical Medicine Insights: Therapeutics;journal;1179559X;0.136;Q3;6;4;41;238;16;41;0.48;59.50;New Zealand;Libertas Academica;2010-ongoing;"Pharmaceutical Science (Q3); Medicine (miscellaneous) (Q4); Pharmacology (Q4)"
620;4000148308;Chinese Traditional and Herbal Drugs;journal;02532670;0.135;Q3;13;664;2149;18233;434;2149;0.2;27.46;China;Chung Tsao Yao Tsa Chih Pien Chi Pu;2006-ongoing;"Complementary and Alternative Medicine (Q3); Pharmaceutical Science (Q3); Drug Discovery (Q4); Pharmacology (medical) (Q4)"
621;21100853513;Pharmaceutical Nanotechnology;journal;22117385, 22117393;0.135;Q3;3;30;6;0;2;6;0;0.00;Netherlands;Bentham Science Publishers B.V.;2014-ongoing;"Pharmaceutical Science (Q3); Biomedical Engineering (Q4)"
622;4000148821;International Journal of Pharmaceutical Compounding;journal;10924221;0.134;Q3;9;63;210;0;47;198;0.22;0.00;United States;International Journal of Pharmaceutical Compounding (Ijpc);2006-ongoing;"Pharmacology (nursing) (Q2); Pharmaceutical Science (Q3); Pharmacy (Q3); Medicine (miscellaneous) (Q4); Pharmacology (medical) (Q4)"
623;19700201333;International Journal of Drug Delivery;journal;09750215;0.131;Q3;11;0;9;0;5;9;0;0.00;United States;Advanced Research Journals;2011-2016 (cancelled);Pharmaceutical Science (Q3)
624;19700200724;Der Pharmacia Lettre;journal;09755071;0.129;Q3;24;0;1332;0;358;1332;0.24;0.00;United States;Scholars Research Library;2011-2016 (cancelled);Pharmaceutical Science (Q3)
625;21100853985;Journal of Xenobiotics;journal;20394705;0.129;Q4;2;0;6;0;1;2;0.5;0.00;Italy;PagePress Publications;2014-ongoing;"Pharmacology (Q4); Pollution (Q4); Toxicology (Q4)"
626;19700201410;Milestones in Drug Therapy;book series;22966056;0.129;Q3;4;0;36;0;6;13;0;0.00;United States;Springer Science + Business Media;2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Drug Discovery (Q4)"
627;21100804474;European Pharmaceutical Journal;journal;24536725;0.128;Q3;5;11;63;216;24;56;0.41;19.64;Germany;de Gruyter;2016-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
628;21100790356;International Journal of Life Sciences Biotechnology and Pharma Research;journal;22503137;0.128;Q3;1;0;1;0;1;1;1;0.00;India;IJLBPR Editorial Office;2012, 2014, 2016-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Applied Microbiology and Biotechnology (Q4)"
629;19700174997;ONdrugDelivery;trade journal;2049145X;0.128;Q3;5;134;274;529;19;168;0.1;3.95;United Kingdom;Frederick Furness Publishing;2009-ongoing;Pharmaceutical Science (Q3)
630;19700181403;Pharmaceutical Outsourcing;journal;19453337, 19453345;0.128;Q3;5;38;207;119;11;180;0.06;3.13;United States;Russell Publishing LLC;2010-ongoing;"Pharmaceutical Science (Q3); Health Policy (Q4)"
631;130170;Phytotherapie;journal;17652847, 16248597;0.128;Q4;12;45;256;1278;54;197;0.3;28.40;Germany;Springer Verlag;2005-ongoing;"Complementary and Alternative Medicine (Q3); Pharmacology (Q4)"
632;19700175149;African Journal Biomedical Research;journal;11195096;0.127;Q3;15;34;110;1082;20;104;0.13;31.82;Nigeria;Bioline International;2008, 2010-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Medicine (miscellaneous) (Q4)"
633;5400152620;American Journal of Pharmacology and Toxicology;journal;15574970, 15574962;0.127;Q3;16;0;13;0;4;11;0.5;0.00;United States;Science Publications;2007-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
634;144613;Journal of Generic Medicines;journal;17411343;0.127;Q3;14;0;49;0;11;39;0.21;0.00;United Kingdom;SAGE Publications Inc.;2003-2017 (cancelled), 2017-2017 (cancelled);Pharmaceutical Science (Q3)
635;19700188422;Research Journal of Pharmaceutical, Biological and Chemical Sciences;journal;09758585;0.127;Q3;24;0;3845;0;935;3845;0.27;0.00;India;RJPBCS;2010-2016 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4)"
636;25197;Revista de Toxicologia;journal;16970748, 02127113;0.127;Q4;9;0;80;0;13;54;0.19;0.00;Spain;Asociacion Espanola de Toxicologia;1989-2017 (cancelled);Toxicology (Q4)
637;21100208082;VacciMonitor;journal;10250298, 1025028X;0.126;Q4;3;15;27;260;3;27;0.13;17.33;Cuba;Instituto Finlay, Centro de Investigacion-Produccion de Vacunas y Sueros;2012-ongoing;"Drug Discovery (Q4); Immunology (Q4); Immunology and Allergy (Q4); Molecular Medicine (Q4)"
638;21374;Fabad Journal of Pharmaceutical Sciences;journal;13004182;0.125;Q4;14;24;30;1612;10;30;0.31;67.17;Turkey;Society of Pharmaceutical Sciences of Ankara;1999-2001, 2003-ongoing;Pharmaceutical Science (Q4)
639;5900153315;Pharmacoeconomics - Spanish Research Articles;journal;1695405X;0.125;Q3;5;5;44;189;4;41;0.11;37.80;Switzerland;Springer International Publishing AG;2007-ongoing;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Health Policy (Q4)"
640;21100784631;AIAA Modeling and Simulation Technologies Conference, 2015;conference and proceedings;00002015;0.124;-;0;0;1;0;0;1;0;0.00;United States;;2015;"Bioengineering; Drug Discovery"
641;21000195625;Asian Journal of Pharmaceutical Research and Health Care;journal;22501444, 22501460;0.124;Q3;4;0;32;0;18;32;0.6;0.00;India;Journal of Pharmaceutical Research and Health Care;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3)
642;59522;Current Therapeutics;journal;0311905X;0.124;Q4;5;0;1;0;0;1;0;0.00;Australia;ADIS Press;1976-1988, 1992, 1994, 1996-2002;Pharmacology (Q4)
643;19700175049;Internet Journal of Toxicology;journal;15593916;0.124;Q4;5;0;1;0;0;1;0;0.00;United States;Internet Scientific Publications;2009-2011, 2013, 2015;Toxicology (Q4)
644;21100854648;Pharmaceutical Crops;journal;22102906;0.124;Q4;1;0;1;0;0;1;0;0.00;Netherlands;Bentham Science Publishers B.V.;2014, 2016-ongoing;"Pharmaceutical Science (Q4); Plant Science (Q4)"
645;21100853008;Pharmacie Globale;journal;09768157;0.124;Q3;0;0;1;0;0;1;0;0.00;India;Pharmacie Globale;2015;"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q3); Pharmacology (medical) (Q4)"
646;21100854216;Pharmanest;journal;09763090, 22310541;0.124;Q4;0;0;1;0;0;1;0;0.00;India;Pharmaceutical Education and Research Society;2014-2015;"Biochemistry (Q4); Biomedical Engineering (Q4); Biotechnology (Q4); Pharmaceutical Science (Q4)"
647;110141;Sangyo eiseigaku zasshi = Journal of occupational health;journal;13410725;0.124;Q4;11;15;70;0;12;70;0.12;0.00;Japan;Nihon Sangyo Eisei Gakkai;1995-ongoing;"Medicine (miscellaneous) (Q4); Public Health, Environmental and Occupational Health (Q4); Toxicology (Q4)"
648;19700175006;Thai Journal of Pharmaceutical Sciences;journal;01254685;0.124;Q4;11;31;125;919;28;125;0.23;29.65;Thailand;Chulalongkorn University;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
649;21265;Drugs of the Future;journal;03778282;0.123;Q4;40;85;274;1920;22;270;0.08;22.59;Spain;Prous Science;1978-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
650;21867;Geneesmiddelenbulletin;journal;03044629;0.123;Q4;6;21;122;242;2;104;0.02;11.52;Netherlands;Stichting Geneesmiddelenbulletin;1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
651;4600151506;Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry;journal;18715222;0.123;Q4;14;10;59;566;14;52;0.16;56.60;United Arab Emirates;Bentham Science Publishers;2006-ongoing;"Endocrinology, Diabetes and Metabolism (Q4); Immunology and Allergy (Q4); Pharmacology (Q4)"
652;19700201521;Journal of Chemical and Pharmaceutical Research;journal;09757384;0.123;Q4;29;0;279;0;89;279;0.39;0.00;India;JOCPR;2011-2014 (cancelled);Pharmaceutical Science (Q4)
653;19700194018;Russian Journal of Biopharmaceuticals;journal;20738099;0.123;Q4;4;50;137;714;25;137;0.28;14.28;Russian Federation;Folium Publishing Company;2011-ongoing;"Bioengineering (Q4); Drug Discovery (Q4)"
654;21100455612;2015 4th International Conference on Future Generation Communication Technology, FGCT 2015;conference and proceedings;00002015;0.122;-;4;0;30;0;13;28;0;0.00;United States;;2015;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
655;9800153152;Archivos Venezolanos de Farmacologia y Terapeutica;journal;07980264;0.122;Q4;4;67;62;2134;23;62;0.36;31.85;Venezuela;Tribuna Medica Venezolana;2007-2013, 2015-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
656;19700175060;International Journal of PharmTech Research;journal;24559563, 09744304;0.122;Q4;40;0;826;0;418;826;0.36;0.00;India;Sphinx Knowledge House;2009-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
657;19700175778;International Journal of Research in Pharmaceutical Sciences;journal;09757538;0.122;Q4;15;256;202;5959;41;202;0.24;23.28;India;JK Welfare & Pharmascope Foundation;2010-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
658;20400195018;International Journal of Pharmacognosy and Phytochemical Research;journal;09754873;0.121;Q4;14;0;526;0;462;526;1.18;0.00;India;International Journal of Pharmacognosy and Phytochemical Research;2011-2016 (cancelled);Drug Discovery (Q4)
659;19700174987;Research Journal of Toxins;journal;18193560;0.121;Q4;2;0;2;0;1;2;0.5;0.00;United States;Academic Journals Inc.;2009, 2014-2016 (cancelled);"Agronomy and Crop Science (Q4); Food Science (Q4); Toxicology (Q4)"
660;17600155051;Drug Delivery Technology;trade journal;15372898;0.12;Q4;9;61;215;373;11;102;0.12;6.11;United States;Drug Delivery Technology, LLC;2009-ongoing;Pharmaceutical Science (Q4)
661;19700174811;European Journal of Parenteral and Pharmaceutical Sciences;journal;17406277;0.12;Q4;5;7;23;20;5;15;0;2.86;United Kingdom;Euromed Communications Ltd;2010-2015;"Pharmacy (Q3); Pharmaceutical Science (Q4)"
662;19600161802;International Journal of Computational Biology and Drug Design;journal;17560764, 17560756;0.12;Q4;12;21;68;830;18;66;0.23;39.52;United Kingdom;Inderscience Enterprises;2008-ongoing;"Computer Science Applications (Q4); Drug Discovery (Q4)"
663;19700188355;International Journal of Phytomedicine;journal;09750185;0.12;Q4;15;0;95;0;16;95;0.22;0.00;United States;Advanced Research Journals;2010-2016 (cancelled);"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
664;21100301603;National Journal of Physiology, Pharmacy and Pharmacology;journal;23204672;0.12;Q4;7;0;499;0;115;497;0.18;0.00;India;Mrs Dipika Charan for MedScience Publishers;2011-2017 (cancelled);"Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Physiology (Q4)"
665;19700175137;Trends in Medical Research;journal;18193587;0.12;Q4;8;0;30;0;11;30;0.47;0.00;United States;Academic Journals Inc.;2008-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
666;21100293201;International Journal of Research in Ayurveda and Pharmacy;journal;22774343, 22293566;0.119;Q4;8;0;30;0;17;30;0.45;0.00;India;Moksha Publishing House;2012-2016 (cancelled);"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
667;50105;Japanese Journal of Neuropsychopharmacology;journal;13434144;0.119;Q4;9;0;52;0;6;49;0.08;0.00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1982-1997, 2002-ongoing;"Clinical Psychology (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
668;21100204506;International Journal of Pharmaceutical Quality Assurance;journal;09759506;0.118;Q4;5;43;66;1101;125;65;2.42;25.60;India;In-IJPQA;2011, 2013-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
669;22906;Journal of China Pharmaceutical University;journal;10005048;0.118;Q4;13;103;330;2581;51;330;0.18;25.06;China;China Pharmaceutical University;1989-1991, 2002-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
670;19700174940;SA Pharmaceutical Journal;journal;10151362;0.118;Q4;6;79;287;976;18;197;0.05;12.35;South Africa;Medpharm Publications Ltd.;2009-ongoing;Pharmaceutical Science (Q4)
671;25247;Chinese Journal of Pharmacology and Toxicology;journal;10003002;0.117;Q4;11;56;448;1739;37;393;0.08;31.05;China;Chung-Kuo Yao Li Hseuh Hui;1986-ongoing;"Pharmacology (Q4); Toxicology (Q4)"
672;19700174925;European Pharmaceutical Review;trade journal;13608606;0.117;Q4;7;53;193;213;20;193;0.07;4.02;United Kingdom;Russell Publishing Ltd;2009-ongoing;"Biochemistry (Q4); Biophysics (Q4); Biotechnology (Q4); Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
673;22375;Indian Drugs;journal;0019462X;0.117;Q4;30;125;318;2673;21;318;0.07;21.38;India;Scientific Publishers;1989-ongoing;"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
674;22977;Journal de Pharmacie de Belgique;journal;00472166;0.117;Q4;12;0;27;0;8;27;0;0.00;Belgium;Algemene Pharmaceutische Bond;1946-2015;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
675;5100152903;Revista Cubana de Plantas Medicinales;journal;10284796;0.117;Q4;11;0;98;0;17;96;0.18;0.00;Cuba;Editorial Ciencias Medicas;1996-1997, 1999-2002, 2005-ongoing;"Drug Discovery (Q4); Pharmacology (Q4); Plant Science (Q4)"
676;22358;U.S. Pharmacist;journal;01484818;0.117;Q4;7;119;449;2028;29;308;0.09;17.04;United States;Jobson Publishing LLC;1979, 1990-1996, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
677;5200152602;Acta Pharmaceutica Sciencia;journal;13072080;0.116;Q4;15;23;39;717;8;35;0.23;31.17;Turkey;Istanbul Medipol University;2006-2011, 2016-ongoing;Pharmaceutical Science (Q4)
678;21279;Eksperimental'naya i Klinicheskaya Farmakologiya;journal;08692092;0.116;Q4;13;90;295;1264;52;295;0.15;14.04;Russian Federation;Izdatel'stvo Meditsina Publishers;1992-ongoing;"Medicine (miscellaneous) (Q4); Pharmacology (Q4); Toxicology (Q4)"
679;21840;Folia Pharmacologica Japonica;journal;00155691, 13478397;0.116;Q4;17;84;329;1941;27;253;0.09;23.11;Japan;Nippon Yakuri Gakkai;1961-ongoing;Pharmacology (Q4)
680;19700182629;Methods in Pharmacology and Toxicology;book series;15572153;0.116;Q4;6;94;124;5146;42;62;30;54.74;United States;Humana Press, Inc.;2008, 2012-ongoing;"Molecular Medicine (Q4); Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
681;21100858119;Pharmaceutical Sciences Asia;journal;25868195, 25868470;0.116;Q4;1;27;21;691;4;21;0.19;25.59;Thailand;Mahidol University - Faculty of Pharmacy;2017-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
682;19700174892;Chinese Journal of Cancer Biotherapy;journal;1007385X;0.115;Q4;3;174;212;4843;15;197;0.07;27.83;China;Chinese Journal of Cancer Biotheraphy;2008-ongoing;"Cancer Research (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
683;19700174645;Journal of International Pharmaceutical Research;journal;16740440;0.115;Q4;8;225;131;5546;16;131;0.07;24.65;India;Journal of International Pharmaceutical Research;2010-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
684;19700182122;Pharmaceuticals Policy and Law;journal;2210495X, 13892827;0.115;Q4;9;23;56;124;9;52;0.27;5.39;Netherlands;IOS Press;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
685;27715;Anil Aggrawal's Internet Journal of Forensic Medicine and Toxicology;journal;09728074;0.114;Q4;9;1;22;10;1;19;0.13;10.00;India;Anil Aggrawal;2000-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
686;19700201516;Journal of Chemical and Pharmaceutical Sciences;journal;09742115;0.114;Q4;11;0;1404;0;266;1404;0.19;0.00;India;SPB Pharma Society;2010-2016 (cancelled);"Biochemistry, Genetics and Molecular Biology (miscellaneous) (Q4); Pharmaceutical Science (Q4); Pharmacology (Q4)"
687;21412;Zeitschrift für Phytotherapie : offizielles Organ der Ges. f. Phytotherapie e.V;journal;0722348X;0.114;Q4;12;70;163;680;6;111;0.08;9.71;Germany;Hippokrates Verlag;1982, 1985-ongoing;"Complementary and Alternative Medicine (Q4); Pharmacology (Q4)"
688;19700201471;International Journal of Pharmacy and Technology;journal;0975766X;0.113;Q4;15;0;2188;0;670;2185;0.31;0.00;India;International Journal of Pharmacy and Technology(IJPT);2011-2016 (cancelled);"Biomedical Engineering (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
689;78698;Japanese Journal of Clinical Pharmacology and Therapeutics;journal;03881601;0.113;Q4;7;32;100;243;6;98;0.06;7.59;Japan;Nihon Rinsho Yakuri Gakkai/Japanese Society of Clinical Pharmacology and Therapeutics;1987-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
690;24097;Journal of the Indian Chemical Society;journal;00194522;0.113;Q4;31;7;611;181;86;611;0.15;25.86;India;Scientific Publishers;1973-1985, 1987-1991, 1996-ongoing;"Drug Discovery (Q4); Electrochemistry (Q4); Inorganic Chemistry (Q4); Organic Chemistry (Q4); Physical and Theoretical Chemistry (Q4)"
691;19978;Ars Pharmaceutica;journal;00042927, 23409894;0.112;Q4;18;0;82;0;15;77;0.23;0.00;Spain;Editorial Universidad de Granada;1980-1981, 1983-1984, 1986-2001, 2003-2017 (cancelled);"History and Philosophy of Science (Q4); Pharmaceutical Science (Q4)"
692;21100854845;Asia Pacific Journal of Medical Toxicology;journal;23222611, 23224320;0.112;Q4;0;0;2;0;0;2;0;0.00;Iran;Mashhad University of Medical Sciences;2016-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
693;21100853979;Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego;journal;20801602;0.112;Q4;1;0;2;0;0;2;0;0.00;Poland;Medical University of Warsaw;2015;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
694;17700156434;Current Pharmacogenomics and Personalized Medicine;journal;18756913, 18756921;0.112;Q4;17;15;56;789;6;50;0.19;52.60;United Arab Emirates;Bentham Science Publishers;2008-ongoing;"Genetics (Q4); Genetics (clinical) (Q4); Molecular Biology (Q4); Molecular Medicine (Q4); Pharmacology (Q4)"
695;21100853531;Indian Journal of Novel Drug Delivery;journal;09755500;0.112;Q4;0;0;2;0;0;2;0;0.00;India;Karnataka Education and Scientific Society;2015-ongoing;Pharmaceutical Science (Q4)
696;21100265336;International Arabic Journal of Antimicrobial Agents;journal;21749094;0.112;Q4;6;0;2;0;0;2;0;0.00;United Kingdom;Internet Medical Publishing;2011-2015;"Microbiology (medical) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
697;19700175098;Klinicka Farmakologie a Farmacie;journal;12127973, 18035353;0.112;Q4;4;14;100;315;2;93;0.04;22.50;Czech Republic;SOLEN s.r.o.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
698;12100156730;Pharmaceutische Weekblad Wetenschappelijk Platform;journal;18738982;0.112;Q4;2;0;8;0;0;2;0;0.00;Netherlands;Kon. Ned. Mij. ter Bevordering der Pharmacie (KNMP);2008, 2013-2015;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
699;19459;Ankara Universitesi Eczacilik Fakultesi Dergisi;journal;10153918;0.111;Q4;9;15;22;407;1;22;0.05;27.13;Turkey;Ankara Universitesi;1997-2001, 2003-2010, 2014, 2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
700;19700175108;Drug Delivery System;journal;09135006;0.111;Q4;7;51;188;749;3;135;0.03;14.69;Japan;Japan Society of Drug Delivery System;2009-ongoing;Pharmaceutical Science (Q4)
701;4700152283;Revista de Ciencias Farmaceuticas Basica e Aplicada;journal;18084532;0.111;Q4;14;0;193;0;7;102;0;0.00;Brazil;Universidade Estadual Paulista (UNESP);2005-ongoing;Pharmaceutical Science (Q4)
702;13000154717;Current Topics in Toxicology;journal;09728228;0.11;Q4;6;0;32;0;6;32;0.17;0.00;India;Research Trends;2007-2009, 2011-ongoing;"Health, Toxicology and Mutagenesis (Q4); Toxicology (Q4)"
703;21100407623;Multimedia Technology IV - Proceedings of the 4th International Conference on Multimedia Technology;conference and proceedings;00002015;0.11;-;2;0;43;0;2;42;0;0.00;Netherlands;;2015;"Health, Toxicology and Mutagenesis; Toxicology"
704;19900192173;International Journal of Pharmaceutical and Clinical Research;journal;09751556;0.109;Q4;9;0;315;0;232;315;0.91;0.00;Australia;International Journal of Pharmaceutical and Clinical Research;2011-2016 (cancelled);"Drug Discovery (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
705;21100205709;International Journal of Toxicological and Pharmacological Research;journal;09755160;0.109;Q4;8;0;114;0;79;114;0.69;0.00;Australia;International Journal of Toxicological and Pharmacological Research;2011-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
706;21127;Pharmaceutical Technology Europe;journal;17537967;0.109;Q4;16;160;429;861;8;361;0.02;5.38;United States;Advanstar Communications Inc.;1998-ongoing;Pharmaceutical Science (Q4)
707;19700201509;Pharma Research;journal;09758216;0.109;Q4;4;0;10;0;1;10;0;0.00;India;Sudarshan Publications;2011-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
708;19700188326;American Journal of Drug Discovery and Development;journal;2150427X, 21504296;0.108;Q4;9;0;3;0;1;3;0;0.00;United States;Academic Journals Inc.;2011-2016 (cancelled);Drug Discovery (Q4)
709;19700174886;Arzneimitteltherapie;journal;07236913;0.108;Q4;6;173;505;877;20;190;0.14;5.07;Germany;Wissenschaftliche Verlagsgesellschaft;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology (nursing) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
710;21100854828;Current Traditional Medicine;journal;22150846, 22150838;0.108;Q4;1;0;3;0;1;3;0;0.00;Netherlands;Bentham Science Publishers B.V.;2015-ongoing;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
711;21100202909;Drug Invention Today;journal;09757619;0.108;Q4;12;525;32;12023;6;32;0.2;22.90;India;Association of Pharmaceutical Innovators;2012-ongoing;Drug Discovery (Q4)
712;11100153311;Iranian Journal of Pharmacology and Therapeutics;journal;17352657;0.108;Q4;18;0;3;0;0;3;0;0.00;Iran;Razi Institute for Drug Research of IUMS;2006-2015;Pharmacology (Q4)
713;19900191564;Journal of International Peacekeeping;journal;18754104, 18754112;0.108;Q4;8;0;40;0;9;38;0;0.00;Netherlands;Brill;1995, 1997, 2001, 2006, 2013-ongoing;"Infectious Diseases (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Virology (Q4)"
714;13718;Pharmaceutical Engineering;journal;02738139;0.108;Q4;13;14;256;41;8;177;0.04;2.93;United States;International Society for Pharmaceutical Engineering, Inc.;1996-ongoing;Pharmaceutical Science (Q4)
715;21102;Pharmaceutical Journal;journal;00316873;0.108;Q4;25;0;742;0;19;197;0.13;0.00;United Kingdom;Pharmaceutical Press;1945-1949, 1994-2012, 2014-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
716;19700175034;Pharmaceutical Processing;trade journal;10499156;0.108;Q4;2;11;106;8;2;9;0.29;0.73;United States;Advantage Business Media;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
717;21716;Pharmazeutische Zeitung;journal;00317136;0.108;Q4;7;561;2339;332;5;1473;0;0.59;Germany;Govi Verlag Pharmazeutischer Verlag GmbH;1947-1948, 1985-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
718;5800207507;Side Effects of Drugs Annual;book series;03786080;0.108;Q4;5;50;148;3307;75;3;20.67;66.14;Netherlands;Elsevier BV;1977-1995, 1997-2005, 2007-ongoing;"Drug Guides (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
719;19700170837;Vitae;journal;01214004;0.108;Q4;11;5;288;176;21;236;0.08;35.20;Colombia;Universidad de Antioquia;2009-ongoing;"Applied Microbiology and Biotechnology (Q4); Bioengineering (Q4); Biotechnology (Q4); Food Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
720;19399;Acta Pharmaceutica Hungarica;journal;00016659;0.107;Q4;12;13;41;356;4;41;0.07;27.38;Hungary;Magyar Gyogyszereszeti Tarsasag/Hungarian Pharmaceutical Association;1965-ongoing;"Medicine (miscellaneous) (Q4); Pharmaceutical Science (Q4)"
721;21100854889;Journal of Applied Pharmacy;journal;19204159;0.107;Q4;1;0;6;0;2;5;0.4;0.00;Canada;Intellectual Consortium of Drug Discovery & Technology Development Inc.;2016-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
722;19700171709;Arhiv za Farmaciju;journal;00041963, 22178767;0.106;Q4;3;0;53;0;2;47;0;0.00;Serbia;Farmaceutsko Drustvo Srbije;1954-1955, 2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
723;22887;Chinese Journal of Antibiotics;journal;10018689;0.106;Q4;10;0;93;0;10;93;0;0.00;China;Editorial Office of the Chinese Journal of Antibiotics;1983-2015;Pharmacology (Q4)
724;19700174922;Chinese Journal of New Drugs;journal;10033734;0.106;Q4;9;498;1578;8238;83;1578;0.05;16.54;China;Chinese Journal of New Drugs Co. Ltd.;2008-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
725;21100853528;International Journal of Advances in Pharmaceutical Research;journal;22307583, 22497226;0.106;Q4;0;0;4;0;0;4;0;0.00;India;International Journal of Advances in Pharmaceutical Research;2014-2015;"Drug Discovery (Q4); Pharmaceutical Science (Q4)"
726;19700175031;Research Journal of Pharmacology;journal;18159362, 19936109;0.106;Q4;7;0;4;0;0;4;0;0.00;Pakistan;Medwell Online;2008-2016 (cancelled);"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
727;19700175121;Azerbaijan Pharmaceutical and Pharmacotherapy Journal;journal;19941951;0.105;Q4;2;14;50;73;2;50;0.06;5.21;Azerbaijan;Azarbaucan Tibb Universiteti;2009-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
728;21100820896;Journal of Advanced Pharmacy Education and Research;journal;22493379;0.105;Q4;2;57;103;2257;14;103;0.14;39.60;India;Society of Pharmaceutical Education & Research [SPER];2017-ongoing;"Education (Q4); Pharmaceutical Science (Q4); Pharmacy (Q4)"
729;21083;Pharmaceutical Care Espana;journal;11396202;0.105;Q4;9;0;61;0;2;48;0.04;0.00;Spain;Fundacion Pharamaceutical Care Espana;2001-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
730;4800154015;S.T.P. Pharma Pratiques;journal;11571497;0.105;Q4;9;4;5;19;0;5;0;4.75;France;Editions de Sante;1991-2014, 2017-ongoing;Pharmaceutical Science (Q4)
731;15323;Journal of Jilin University Medicine Edition;journal;1671587X;0.104;Q4;5;211;547;3405;33;547;0.08;16.14;China;Jilin University;2005-ongoing;Pharmacology (Q4)
732;86349;Oral Therapeutics and Pharmacology;journal;02881012;0.104;Q4;5;11;34;188;2;34;0.04;17.09;Japan;Shika Yakubutsu Ryoho Kenkyukai;1984-ongoing;"Dentistry (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4)"
733;21243;Pharmacy times;trade journal;00030627;0.104;Q4;8;196;776;992;7;149;0.02;5.06;United States;Romaine Pierson Publishers;1947-1949, 1975, 1977-1987, 2007-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
734;21100829255;Chinese Journal of Pharmaceutical Biotechnology;journal;10058915;0.103;Q4;4;81;371;1696;19;371;0.06;20.94;China;China Pharmaceutical University;2007-ongoing;"Applied Microbiology and Biotechnology (Q4); Pharmaceutical Science (Q4)"
735;10600153336;Innovations in Pharmaceutical Technology;trade journal;14717204;0.103;Q4;6;47;101;122;2;101;0.02;2.60;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2007-2010, 2012-ongoing;Pharmaceutical Science (Q4)
736;21100853545;Journal of Global Trends in Pharmaceutical Sciences;journal;22307346;0.103;Q4;0;0;9;0;0;9;0;0.00;India;Annamacharya College of Pharmacy;2015-ongoing;"Molecular Medicine (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
737;5200152604;Pharma Times;journal;00316849;0.103;Q4;10;47;255;671;2;123;0.02;14.28;India;Indian Pharmaceutical Association;2006-ongoing;Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
738;21836;Revista Mexicana de Ciencias Farmaceuticas;journal;10273956;0.103;Q4;8;0;20;0;2;17;0;0.00;Mexico;Asociacion Farmaceutica Mexicana;1997-2015;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
739;21800;Farmacevtski Vestnik;journal;00148229;0.102;Q4;4;0;123;0;3;116;0.02;0.00;Slovenia;Slovensko Farmacevtsko Drustvo;1961, 1989-2016 (cancelled);"Pharmaceutical Science (Q4); Pharmacology (Q4)"
740;21100202747;GMP Review;trade journal;14764547;0.102;Q4;2;9;14;24;0;11;0;2.67;United Kingdom;Euromed Communications Ltd;2011-2015;Pharmaceutical Science (Q4)
741;18098;Japanese Journal of Psychopharmacology;journal;13402544;0.102;Q4;11;0;11;0;0;11;0;0.00;Japan;Nihon Shinkei Seishin Yakuri Gakkai/Japanese Society of Neuropsychophamacology;1981-2017;"Clinical Psychology (Q4); Medicine (miscellaneous) (Q4); Pharmacology (Q4); Pharmacology (medical) (Q4); Psychiatry and Mental Health (Q4)"
742;5700165173;Journal of Medical Marketing;journal;17457912, 17457904;0.102;Q4;15;2;16;0;1;10;0;0.00;United States;SAGE Publications Inc.;2000-ongoing;"Marketing (Q4); Medicine (miscellaneous) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4); Strategy and Management (Q4)"
743;94365;Journal of Phytomedicine and Therapeutics;journal;11181028;0.102;Q4;5;0;12;0;0;12;0;0.00;Nigeria;National Institute for Pharmaceutical Research and Development;2000-2003, 2007, 2009;Pharmacology (Q4)
744;19700188437;Open Access Journal of Medicinal and Aromatic Plants;journal;09747877;0.102;Q4;6;0;12;0;1;12;0;0.00;India;Medicinal and Aromatic Plants Association of India;2010-ongoing;"Complementary and Alternative Medicine (Q4); Drug Discovery (Q4)"
745;19700174966;Pharmakeftiki;journal;11054999;0.102;Q4;2;7;22;239;2;22;0.14;34.14;Greece;Papathanasopoulos;2008-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
746;21100853960;Anti-Tumor Pharmacy;journal;20951264;0.101;Q4;1;0;33;0;1;33;0.04;0.00;China;Editorial Department of Anti-tumor Pharmacy;2014-ongoing;"Oncology (Q4); Pharmaceutical Science (Q4); Pharmacology (medical) (Q4)"
747;21100781407;EMC Seattle 2016 - 34th Annual West Coast Energy Management Congress;conference and proceedings;00002016;0.101;-;0;0;29;0;0;28;0;0.00;Hong Kong;;2016;"Health, Toxicology and Mutagenesis; Pollution; Toxicology"
748;21795;Farmaceuticky Obzor;journal;00148172;0.101;Q4;7;0;26;0;0;26;0;0.00;Slovakia;Ministerstvo Zdravotnictva;1961-1963, 1974, 1976-2016 (cancelled);Pharmaceutical Science (Q4)
749;21100199794;Industrial Pharmacy;trade journal;17414911;0.101;Q4;4;0;15;0;0;15;0;0.00;United Kingdom;Euromed Communications Ltd;2011-ongoing;Pharmaceutical Science (Q4)
750;25110;International Journal of Medical Toxicology and Legal Medicine;journal;09720448;0.101;Q4;8;88;29;1488;0;29;0;16.91;India;All India Institute of Medical Sciences;1999-2003, 2005-2011, 2017-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
751;19700188356;Journal of Excipients and Food Chemicals;journal;21502668;0.101;Q4;13;9;29;224;10;18;0.62;24.89;United States;IPEC-Americas;2010-ongoing;"Food Science (Q4); Pharmaceutical Science (Q4)"
752;11200153306;Journal of Pharmacology and Toxicology;journal;1816496X;0.101;Q4;15;0;18;0;0;18;0;0.00;United States;Academic Journals Inc.;2008-2016 (cancelled);Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)
753;21142;Pharmaceutisch Weekblad;journal;00316911;0.101;Q4;9;472;1220;473;5;680;0.01;1.00;Netherlands;Royal Netherlands Pharmaceutical Society;1948-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
754;19700175580;PharmacoVigilance Review;journal;17526752;0.101;Q4;1;4;34;1;0;26;0;0.25;United Kingdom;Euromed Communications Ltd;2010-ongoing;"Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
755;21100812575;Process Development Division 2016 - Core Programming Area at the 2016 AIChE Meeting;conference and proceedings;00002016;0.101;-;0;0;20;0;0;19;0;0.00;United States;;2016;"Bioengineering; Food Science; Pharmaceutical Science"
756;21828;Revista Cubana de Farmacia;journal;00347515, 15612988;0.101;Q4;8;0;159;0;5;149;0.01;0.00;Cuba;Editorial Ciencias Medicas;1980-1991, 1996-2000, 2002, 2004-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4); Pharmacy (Q4)"
757;19900195040;Therapeutics, Pharmacology and Clinical Toxicology;journal;15830012;0.101;Q4;3;0;34;0;2;34;0.2;0.00;Romania;Rp Publishing House;2011-2012, 2014-ongoing;"Pharmacology (medical) (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
758;21100463816;39th International Precious Metals Conference: Charting Precious Metals through the Changing Currents of Compliance, Finance, Consumer Trends, Risk and New Technology, IPMI 2015;conference and proceedings;00002015;0.1;-;1;0;56;0;0;55;0;0.00;United States;;2015;"Organic Chemistry; Pharmaceutical Science"
759;25253;Blutalkohol;journal;00065250;0.1;Q4;13;0;91;0;3;78;0.02;0.00;Germany;Springer Verlag;1974-2017 (cancelled);"Medicine (miscellaneous) (Q4); Toxicology (Q4)"
760;20628;Circular Farmaceutica;journal;00097314;0.1;Q4;2;18;83;179;0;67;0;9.94;Spain;Colegio Official de Farmaceuticos de la Provincia de Barcelona;1961, 1973-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
761;19700173109;Contract Pharma;trade journal;15443469;0.1;Q4;3;41;339;87;2;339;0;2.12;United States;Contract Pharma;2009-ongoing;"Industrial Relations (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
762;21238;Drug Topics;journal;00126616;0.1;Q4;7;62;709;61;13;84;0.14;0.98;United States;Advanstar Communications Inc.;1991, 1997-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
763;50087;EBR - European Biopharmaceutical Review;journal;13690663;0.1;Q4;5;46;106;344;1;84;0.02;7.48;United Kingdom;Samedan Ltd.;2004-ongoing;Pharmaceutical Science (Q4)
764;21334;EPC - European Pharmaceutical Contractor;journal;1364369X;0.1;Q4;3;0;44;0;0;40;0;0.00;United Kingdom;Samedan Ltd.;2002-ongoing;Pharmaceutical Science (Q4)
765;21798;Farmaceutski Glasnik;journal;00148202;0.1;Q4;5;89;225;842;2;185;0.01;9.46;Croatia;Hrvatsko Farmaceutsko Drustvo/Croatian Pharmaceutical Society;1950-1951, 1962, 1990-ongoing;"Pharmaceutical Science (Q4); Pharmacology (Q4)"
766;22514;Japanese Journal of Chemotherapy;journal;13407007;0.1;Q4;12;24;69;678;1;69;0;28.25;Japan;Nihon Kagaku Ryoho Gakkai/Japan Society of Chemotherapy;1995-ongoing;"Pharmacology (Q4); Pharmacology (medical) (Q4)"
767;19900194914;Journal of Punjab Academy of Forensic Medicine and Toxicology;journal;0974083X, 09725687;0.1;Q4;6;23;92;301;5;86;0.06;13.09;India;Punjab Academy of Forensic Medicine and Toxicology;2011-ongoing;"Pathology and Forensic Medicine (Q4); Toxicology (Q4)"
768;13637;Manufacturing Chemist;journal;02624230;0.1;Q4;6;91;89;114;1;89;0.01;1.25;United Kingdom;Polygon Media Ltd.;1981-1984, 1986, 1989, 1996-2001, 2006-ongoing;Pharmaceutical Science (Q4)
769;19700181430;Pharmaceutical Manufacturing and Packing Sourcer;trade journal;14631245;0.1;Q4;3;39;86;53;0;86;0;1.36;United Kingdom;Samedan Pharmaceutical Publishers Ltd.;2009-ongoing;"Pharmaceutical Science (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)"
770;18633;Herba Polonica;journal;00180599;;-;1;27;0;920;0;0;0;34.07;Poland;Instytut Roslin i Przetworow Zielarskich;1973-1979, 2018-ongoing;"Complementary and Alternative Medicine; Ecology, Evolution, Behavior and Systematics; Pharmacology; Plant Science"
771;21100867470;Indonesian Journal of Pharmacy;journal;23389486, 23389427;;-;1;20;0;568;0;0;0;28.40;Indonesia;Universitas Gadjah Mada - Faculty of Pharmacy;2018-ongoing;"Pharmaceutical Science; Pharmacology (medical); Pharmacy"
772;21100862294;Neuropsychopharmacology Reports;journal;2574173X;;-;2;29;0;944;0;0;0;32.55;United States;John Wiley and Sons Inc.;2018-ongoing;"Clinical Psychology; Pharmacology; Pharmacology (medical); Psychiatry and Mental Health"
